(dp0
(S'ZEB1'
p1
S'FOXA1'
p2
S'increases'
p3
tp4
(lp5
s(S'FOXJ1'
p6
S'GATA6'
p7
S'increases'
p8
tp9
(lp10
s(S'TFAP4'
p11
S'FOXD3'
p12
S'increases'
p13
tp14
(lp15
s(S'TBP'
p16
S'MEIS1'
p17
S'increases'
p18
tp19
(lp20
s(S'GCM1'
p21
S'GATA6'
p22
S'increases'
p23
tp24
(lp25
s(S'T-DHT'
p26
S'SRC'
p27
S'adds_modification'
p28
tp29
(lp30
s(S'MAZ'
p31
S'GABPB2'
p32
S'increases'
p33
tp34
(lp35
s(S'HMGA1'
p36
S'EN1'
p37
S'increases'
p38
tp39
(lp40
s(S'CYP26A1'
p41
S'NRAS'
p42
S'increases'
p43
tp44
(lp45
s(S'CUX1'
p46
S'MEIS1'
p47
S'increases'
p48
tp49
(lp50
s(S'REPIN1'
p51
S'BACH1'
p52
S'increases'
p53
tp54
(lp55
s(S'TFDP1'
p56
S'HOXA9'
p57
S'increases'
p58
tp59
(lp60
s(S'NFE2L1'
p61
S'CYP26A1'
p62
S'increases'
p63
tp64
(lp65
s(S'MAZ'
p66
S'GATA1'
p67
S'increases'
p68
tp69
(lp70
S'In bone-specific interaction cluster, there are seven TFs: EF-C, MAZ, MIF1, GATA1, GATA2, GATA3 and RFX1.'
p71
as(S'TCF12'
p72
S'GABPB2'
p73
S'increases'
p74
tp75
(lp76
s(S'ETS2'
p77
S'FOXO3'
p78
S'increases'
p79
tp80
(lp81
s(S'hsa-let-7c-5p'
p82
S'NRAS'
p83
S'decreases'
p84
tp85
(lp86
s(S'SPI1'
p87
S'CYP26A1'
p88
S'increases'
p89
tp90
(lp91
s(S'RAC1/GTP'
p92
S'MKK4'
p93
S'adds_modification'
p94
tp95
(lp96
s(S'Quercetin'
p97
S'KRAS MRNA'
p98
S'decreases'
p99
tp100
(lp101
s(S'INSULIN RECEPTOR/INSULIN/SHC'
p102
S'GRB2'
p103
S'binds'
p104
tp105
(lp106
s(S'TAp63a (tetramer)'
p107
S'PKC DELTA'
p108
S'increases'
p109
tp110
(lp111
s(S'FOXO1'
p112
S'POU2F1'
p113
S'increases'
p114
tp115
(lp116
s(S'FOXL1'
p117
S'EN1'
p118
S'increases'
p119
tp120
(lp121
s(S'TBP'
p122
S'CYP26A1'
p123
S'increases'
p124
tp125
(lp126
s(S'Heptachlor'
p127
S'HRAS MRNA'
p128
S'decreases'
p129
tp130
(lp131
s(S'PCBP1'
p132
S'CYP26A1'
p133
S'increases'
p134
tp135
(lp136
s(S'ZBTB18'
p137
S'CYP26A1'
p138
S'increases'
p139
tp140
(lp141
s(S'GATA2'
p142
S'CYP26A1'
p143
S'increases'
p144
tp145
(lp146
s(S'Cadmium'
p147
S'KRAS MRNA'
p148
S'increases'
p149
tp150
(lp151
s(S'HNF1A'
p152
S'POU2F1'
p153
S'increases'
p154
tp155
(lp156
s(S'ABT-100'
p157
S'HRAS PROTEIN'
p158
S'inhibits_modification'
p159
tp160
(lp161
s(S'ELF1'
p162
S'CYP26A1'
p163
S'increases'
p164
tp165
(lp166
s(S'LEF1'
p167
S'KRAS'
p168
S'increases'
p169
tp170
(lp171
s(S'NKX2-1'
p172
S'FOXD3'
p173
S'increases'
p174
tp175
(lp176
s(S'PI-3-4-5-P3'
p177
S'BTK-ITK'
p178
S'translocates'
p179
tp180
(lp181
s(S'POU6F1'
p182
S'HOXA9'
p183
S'increases'
p184
tp185
(lp186
s(S'Myb'
p187
S'MYB'
p188
S'increases'
p189
tp190
(lp191
S'To gain insight into the mechanisms by which the Myb transcription factor controls normal hematopoiesis and particularly, how it contributes to leukemogenesis, we mapped the genome-wide occupancy of Myb by chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-Seq) in ERMYB myeloid progenitor cells.'
p192
aS'We next examined genome-wide Myb occupancy pattern in ERMYB cells using ChIP-Seq.'
p193
aS'To provide further confidence, we carried out ChIP using pooled MYB antibodies (Myb 1-1 antibody and Thelma sera) in HL-60 cells, human leukemic pro-myeloblasts that represent a similar stage to ERMYB cells in myeloid development.'
p194
as(S'PAX5'
p195
S'CYP26A1'
p196
S'increases'
p197
tp198
(lp199
s(S'FOXO4'
p200
S'FOXD3'
p201
S'increases'
p202
tp203
(lp204
S'In addition, sites for AP1, CREB, C/EBP, CCAAT-box factors, forkhead factors (FOXA, FOXD3, FOXO4, HFH8), E2F, GATA factors, GC-box factors, MAZR and PAX factors were enriched in down-regulated secondary target genes (Supplementary Tables 1 and 2).'
p205
as(S'CYP26A1'
p206
S'FOXO4'
p207
S'increases'
p208
tp209
(lp210
s(S'cell adhesion'
p211
S'HRAS/GDP'
p212
S'increases_activity'
p213
tp214
(lp215
s(S'IRF7'
p216
S'CYP26A1'
p217
S'increases'
p218
tp219
(lp220
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p221
S'KRAS PROTEIN'
p222
S'increases'
p223
tp224
(lp225
s(S'PITX2'
p226
S'POU2F1'
p227
S'increases'
p228
tp229
(lp230
s(S'E2F1'
p231
S'CYP26A1'
p232
S'increases'
p233
tp234
(lp235
s(S'ATF1'
p236
S'CYP26A1'
p237
S'increases'
p238
tp239
(lp240
s(S'PI3K'
p241
S'PKC DELTA'
p242
S'adds_modification'
p243
tp244
(lp245
s(S'SOX5'
p246
S'HOXA9'
p247
S'increases'
p248
tp249
(lp250
s(S'FOXO4'
p251
S'POU2F1'
p252
S'increases'
p253
tp254
(lp255
s(S'FOXO4'
p256
S'GATA6'
p257
S'increases'
p258
tp259
(lp260
s(S'LEF1'
p261
S'FOXF2'
p262
S'increases'
p263
tp264
(lp265
s(S'Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos'
p266
S'HRAS/GDP'
p267
S'increases_activity'
p268
tp269
(lp270
s(S'TLX2'
p271
S'RUNX1'
p272
S'increases'
p273
tp274
(lp275
s(S'ALX4'
p276
S'JUN'
p277
S'increases'
p278
tp279
(lp280
s(S'RHOA/GTP'
p281
S'RHOGDI'
p282
S'binds'
p283
tp284
(lp285
s(S'GCM1'
p286
S'CYP26A1'
p287
S'increases'
p288
tp289
(lp290
s(S'RB1'
p291
S'ONECUT1'
p292
S'increases'
p293
tp294
(lp295
s(S'NHLH1'
p296
S'CYP26A1'
p297
S'increases'
p298
tp299
(lp300
s(S'NR3C1'
p301
S'BACH1'
p302
S'increases'
p303
tp304
(lp305
s(S'HNF4A'
p306
S'CYP26A1'
p307
S'increases'
p308
tp309
(lp310
s(S'YY1'
p311
S'FOXO3'
p312
S'increases'
p313
tp314
(lp315
s(S'GRB2:SOS1'
p316
S'P-EGFR MUTANTS DIMER'
p317
S'binds'
p318
tp319
(lp320
s(S'P-Y349,350-SHC1:P-ERBB4'
p321
S'GRB2:SOS1'
p322
S'binds'
p323
tp324
(lp325
s(S'FOXN1'
p326
S'ONECUT1'
p327
S'increases'
p328
tp329
(lp330
s(S'TFAP4'
p331
S'MYC'
p332
S'increases'
p333
tp334
(lp335
s(S'MYC'
p336
S'EN1'
p337
S'increases'
p338
tp339
(lp340
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p341
S'SHC/GRB2/SOS1'
p342
S'increases_activity'
p343
tp344
(lp345
s(S'14-3-3 BETA, ZETA'
p346
S'GARNL4'
p347
S'binds'
p348
tp349
(lp350
s(S'SMAD1'
p351
S'EN1'
p352
S'increases'
p353
tp354
(lp355
s(S'Raf-1'
p356
S'MEK1-2'
p357
S'adds_modification'
p358
tp359
(lp360
s(S'POU2F1'
p361
S'FOXO3'
p362
S'increases'
p363
tp364
(lp365
s(S'NGF (dimer)/TRKA'
p366
S'RASGRF1'
p367
S'adds_modification'
p368
tp369
(lp370
s(S'TCF4'
p371
S'CYP26A1'
p372
S'increases'
p373
tp374
(lp375
s(S'STAT5B'
p376
S'TLX2'
p377
S'increases'
p378
tp379
(lp380
s(S'CYP26A1'
p381
S'SRF'
p382
S'increases'
p383
tp384
(lp385
s(S'STAT1'
p386
S'NRAS'
p387
S'increases'
p388
tp389
(lp390
s(S'TFDP1'
p391
S'GATA1'
p392
S'increases'
p393
tp394
(lp395
s(S'PI3K'
p396
S'ALPHA6/BETA4 INTEGRIN/LAMININ'
p397
S'binds'
p398
tp399
(lp400
s(S'FOXF2'
p401
S'NRAS'
p402
S'increases'
p403
tp404
(lp405
s(S'CUX1'
p406
S'POU2F1'
p407
S'increases'
p408
tp409
(lp410
s(S'ETS2'
p411
S'STAT4'
p412
S'increases'
p413
tp414
(lp415
s(S'EN1'
p416
S'CYP26A1'
p417
S'increases'
p418
tp419
(lp420
s(S'COMPLEX (RAS/GTP)'
p421
S'RAF'
p422
S'binds'
p423
tp424
(lp425
s(S'LEF1'
p426
S'EN1'
p427
S'increases'
p428
tp429
(lp430
s(S'FOXL1'
p431
S'NRAS'
p432
S'increases'
p433
tp434
(lp435
s(S'ELF2'
p436
S'CYP26A1'
p437
S'increases'
p438
tp439
(lp440
s(S'Src Family Kinases-active'
p441
S'EGF/EGFR'
p442
S'adds_modification'
p443
tp444
(lp445
s(S'RUNX1'
p446
S'POU2F1'
p447
S'increases'
p448
tp449
(lp450
s(S'RHOA/GTP'
p451
S'CITRON-N'
p452
S'increases_activity'
p453
tp454
(lp455
s(S'PAX4'
p456
S'SRF'
p457
S'increases'
p458
tp459
(lp460
s(S'Vitamin E'
p461
S'HRAS MRNA'
p462
S'increases'
p463
tp464
(lp465
s(S'CDX2'
p466
S'FOXD3'
p467
S'increases'
p468
tp469
(lp470
s(S'Plant Extracts'
p471
S'KEAP1 PROTEIN'
p472
S'decreases'
p473
tp474
(lp475
s(S'PAX4'
p476
S'CBFA2T3'
p477
S'increases'
p478
tp479
(lp480
s(S'FOXD1'
p481
S'CYP26A1'
p482
S'increases'
p483
tp484
(lp485
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p486
S'VAV1'
p487
S'adds_modification'
p488
tp489
(lp490
s(S'PCBP1'
p491
S'MEIS1'
p492
S'increases'
p493
tp494
(lp495
s(S'FOXI1'
p496
S'FOXD3'
p497
S'increases'
p498
tp499
(lp500
s(S'GATA4'
p501
S'MEIS1'
p502
S'increases'
p503
tp504
(lp505
s(S'STAT5B'
p506
S'CEBPG'
p507
S'increases'
p508
tp509
(lp510
s(S'TFDP2'
p511
S'MAZ'
p512
S'increases'
p513
tp514
(lp515
s(S'PI3K'
p516
S'SHP2'
p517
S'binds'
p518
tp519
(lp520
s(S'SPI1'
p521
S'ONECUT1'
p522
S'increases'
p523
tp524
(lp525
s(S'STAT6'
p526
S'EN1'
p527
S'increases'
p528
tp529
(lp530
s(S'TLX2'
p531
S'CYP26A1'
p532
S'increases'
p533
tp534
(lp535
s(S'RAF1'
p536
S'MEK1-2'
p537
S'increases_activity'
p538
tp539
(lp540
s(S'STAT5A'
p541
S'IRF1'
p542
S'increases'
p543
tp544
(lp545
s(S'2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine'
p546
S'HRAS MRNA'
p547
S'increases'
p548
tp549
(lp550
s(S'MAZ'
p551
S'POU2F1'
p552
S'increases'
p553
tp554
(lp555
s(S'MAZ'
p556
S'SRF'
p557
S'increases'
p558
tp559
(lp560
s(S'GATA1'
p561
S'JUN'
p562
S'increases'
p563
tp564
(lp565
s(S'FOXA1'
p566
S'NRAS'
p567
S'increases'
p568
tp569
(lp570
s(S'STAT1'
p571
S'EN1'
p572
S'increases'
p573
tp574
(lp575
s(S'GTF2A2'
p576
S'MAX'
p577
S'increases'
p578
tp579
(lp580
s(S'LMO2'
p581
S'EN1'
p582
S'increases'
p583
tp584
(lp585
s(S'MYOD1'
p586
S'LEF1'
p587
S'increases'
p588
tp589
(lp590
s(S'ATF3'
p591
S'JUN'
p592
S'increases'
p593
tp594
(lp595
S'AP1 also binds to the cAMP response element (CRE; TGACGTCA) when the dimer is formed by ATF3/JUN ('
p596
as(S'GRB2:SOS1'
p597
S'ACTIVATED FGFR:P-SHC1'
p598
S'binds'
p599
tp600
(lp601
s(S'MAFG'
p602
S'BACH1'
p603
S'increases'
p604
tp605
(lp606
s(S'POU3F2'
p607
S'POU2F1'
p608
S'increases'
p609
tp610
(lp611
s(S'K 7174'
p612
S'KRAS MRNA'
p613
S'increases'
p614
tp615
(lp616
s(S'POU1F1'
p617
S'RUNX1'
p618
S'increases'
p619
tp620
(lp621
s(S'HRAS protein'
p622
S'CCND1 MRNA'
p623
S'increases'
p624
tp625
(lp626
s(S'YY1'
p627
S'EN1'
p628
S'increases'
p629
tp630
(lp631
s(S'resveratrol'
p632
S'HRAS MRNA'
p633
S'increases'
p634
tp635
(lp636
s(S'NKX2-1'
p637
S'HOXA9'
p638
S'increases'
p639
tp640
(lp641
s(S'HSF1'
p642
S'CYP26A1'
p643
S'increases'
p644
tp645
(lp646
s(S'MYC'
p647
S'HOXA9'
p648
S'increases'
p649
tp650
(lp651
s(S'Raf'
p652
S'MEK'
p653
S'adds_modification'
p654
tp655
(lp656
S'Activated Ras stimulates the ERK-MAP kinase cascade through the sequential phosphorylation of Raf, MEK and ERK.'
p657
aS'The Raf/MEK/ERK cascade is a therapeutic target in human cancers with deregulated Ras signaling, which includes tumours that have inactivated the '
p658
aS'Cell intrinsic defects in the generation of T cells generally map to either T cell receptor (TCR) proximal signaling molecules or to two major pathways: the calcineurin/NFAT and Raf/MEK/Erk pathway '
p659
aS'Antibodies used were as follows: SMYD3 and MAP3K2me2/3 (generated by Yenzym); GST (generated by Covance); beta-Tubulin (05-661 Millipore); MAP3K2 (1662-1 Epitomics); Flag and ERK5 (F1804, E1523, Sigma); pERK1/2 and ERK1/2 and pMEK1/2 and MEK1/2 and pJNK and JNK and pP38 and P38 and pERK5 and pAKT and AKT and pCRaf and CRaf, PPP2R2a (4370, 4695, 9121, 9122, 9251, 9252, 9211, 9212, 3371, 2965, 4685, 9427, 9422, 5689, Cell Signaling); HA and Myc (26183, 21316 Pierce).'
p660
aS'Sorafenib is an oral multikinase inhibitor that blocks tumour cell proliferation by targeting the Raf/MEK/ERK signalling pathway and exerts an antiangiogenic effect by targeting the tyrosine kinases of vascular endothelial growth factor receptor (VEGFR)-2, VEGFR-3, and platelet-derived growth factor receptor (PDGFR)-beta['
p661
aS'In turn, activated ERK1/2 can phosphorylate downstream substrates, such as c-Raf-1, MEK, Elk-1 and c-Fos, which regulate a variety of genes and proteins involved in apoptosis, such as bcl-2, caspase-3 and FasL['
p662
aS'In mammalian cells, ERK1/2 can be activated by a variety of stimuli, and in turn, the activated ERK1/2 can typically phosphorylate a number of downstream substrates, such as c-Raf-1, MEK, Elk-1, and c-Fos (Satoh et al., 2000).'
p663
aS'To confirm the role of RTK signalling pathways in EBV infection, EGF-treated HNE1 and NPEC1-Bmi1 cells pre-incubated with inhibitors of tyrosine kinases (Genistein), MEK1/MEK2 (U0126), PI3K/AKT (LY294002), EGFR (Gefitinib) and VEGFR2/PDGFR/Raf signalling cascades (Sorafenib), were infected with EBV.'
p664
aS'It has been previously reported that Raf/MEK/ERK signalling was linked to DNA damage response and DNA repair through an ATM-dependent process'
p665
aS'One of the identified Smad2/3 partners was Araf, a member of Raf kinase family that, upon activation by Ras, normally activate MEK/ERKs'
p666
aS'We propose that growth factor stimulation results in the docking of the ERK cascade components, Raf, MEK and ERK onto the cytoplasmic face of autophagic structures.'
p667
aS'The two major Ras effector pathways that control cell proliferation and survival are Raf-MEK-ERK and PI3-K-AKT, respectively'
p668
aS'Among these are MAPKs of the extracellular signal-regulated kinase (ERK) signalling pathway, including B-Raf (B-rapidly accelerated fibrosarcoma), MEK1 (MAPK or ERK kinase), ERK1/2 (ERKs 1 and 2) and kinase p38 (MAPK p38; overview in ref. '
p669
aS'The recombinant protein kinases (Raf, MEK and ERK) were purchased from Upstate Biotechnology.'
p670
aS'To identify the MAPK responsible for phosphorylation of PAP, we attempted to phosphorylate PAP using purified MAPKs Raf, MEK and ERK '
p671
aS'Extracellular mitogenic signals (triangles) leads to activation of Ras and the signaling through the Raf-MEK-ERK (MAPK) cascade to activate transcription factors such as Elk-1 and RREB1 resulting in proliferation and growth responses.'
p672
aS'It was reported that E2F1 is located downstream of the MAPK signaling pathway and is activated by activation of the PKC/Raf/MEK/ERK pathway ('
p673
as(S'TFDP1'
p674
S'MAZ'
p675
S'increases'
p676
tp677
(lp678
s(S'SPRED1'
p679
S'HRAS'
p680
S'binds'
p681
tp682
(lp683
s(S'MYCN'
p684
S'CYP26A1'
p685
S'increases'
p686
tp687
(lp688
s(S'AHR'
p689
S'FOXD3'
p690
S'increases'
p691
tp692
(lp693
s(S'SF1'
p694
S'CYP26A1'
p695
S'increases'
p696
tp697
(lp698
s(S'MEIS1'
p699
S'ETS1'
p700
S'increases'
p701
tp702
(lp703
s(S'Copper Sulfate'
p704
S'HRAS MRNA'
p705
S'decreases'
p706
tp707
(lp708
s(S'MAZ'
p709
S'MYC'
p710
S'increases'
p711
tp712
(lp713
s(S'E4F1'
p714
S'HOXA9'
p715
S'increases'
p716
tp717
(lp718
s(S'GATA1'
p719
S'GATA6'
p720
S'increases'
p721
tp722
(lp723
s(S'RUNX2'
p724
S'POU2F1'
p725
S'increases'
p726
tp727
(lp728
s(S'CYP26A1'
p729
S'GATA6'
p730
S'increases'
p731
tp732
(lp733
s(S'PAX4'
p734
S'GATA1'
p735
S'increases'
p736
tp737
(lp738
s(S'ELF2'
p739
S'STAT5A'
p740
S'increases'
p741
tp742
(lp743
s(S'CART1'
p744
S'NRAS'
p745
S'increases'
p746
tp747
(lp748
s(S'IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc'
p749
S'HRAS/GDP'
p750
S'increases_activity'
p751
tp752
(lp753
s(S'RB1'
p754
S'CYP26A1'
p755
S'increases'
p756
tp757
(lp758
s(S'CEBPG'
p759
S'HOXA9'
p760
S'increases'
p761
tp762
(lp763
s(S'GRB2/SOS1/SHC'
p764
S'IGF-1R HETEROTETRAMER/IGF1'
p765
S'binds'
p766
tp767
(lp768
s(S'PRRX2'
p769
S'CYP26A1'
p770
S'increases'
p771
tp772
(lp773
s(S'TEAD1'
p774
S'CYP26A1'
p775
S'increases'
p776
tp777
(lp778
s(S'STAT5A'
p779
S'FOXA1'
p780
S'increases'
p781
tp782
(lp783
s(S'ATF2'
p784
S'FOXD3'
p785
S'increases'
p786
tp787
(lp788
s(S'REPIN1'
p789
S'FOXO4'
p790
S'increases'
p791
tp792
(lp793
s(S'FOXF2'
p794
S'ETS1'
p795
S'increases'
p796
tp797
(lp798
s(S'ETV7'
p799
S'MEIS1'
p800
S'increases'
p801
tp802
(lp803
s(S'RUNX2'
p804
S'RUNX1'
p805
S'increases'
p806
tp807
(lp808
s(S'OR5I1'
p809
S'GATA1'
p810
S'increases'
p811
tp812
(lp813
s(S'MSX1'
p814
S'EN1'
p815
S'increases'
p816
tp817
(lp818
s(S'GTF3A'
p819
S'IRF1'
p820
S'increases'
p821
tp822
(lp823
s(S'POU2F1'
p824
S'SRF'
p825
S'increases'
p826
tp827
(lp828
s(S'PLC-GAMMA'
p829
S'COMPLEX (GADS/SLP-76)'
p830
S'binds'
p831
tp832
(lp833
s(S'STAT4'
p834
S'STAT5A'
p835
S'increases'
p836
tp837
(lp838
S'The STAT (signal transducers and activators of transcription) family of transcription factors comprises seven members (STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6), which are essential mediators of cytokine, growth factor and hormone responses.'
p839
as(S'JUN'
p840
S'BACH1'
p841
S'increases'
p842
tp843
(lp844
s(S'POU1F1'
p845
S'HOXA9'
p846
S'increases'
p847
tp848
(lp849
s(S'docetaxel'
p850
S'HRAS PROTEIN'
p851
S'increases'
p852
tp853
(lp854
s(S'MAX'
p855
S'LEF1'
p856
S'increases'
p857
tp858
(lp859
s(S'FOXA1'
p860
S'CYP26A1'
p861
S'increases'
p862
tp863
(lp864
s(S'GATA4'
p865
S'FOXD3'
p866
S'increases'
p867
tp868
(lp869
s(S'ZBTB18'
p870
S'RUNX1'
p871
S'increases'
p872
tp873
(lp874
s(S'ATF3'
p875
S'RUNX1'
p876
S'increases'
p877
tp878
(lp879
s(S'NKX2-1'
p880
S'CYP26A1'
p881
S'increases'
p882
tp883
(lp884
s(S'NR3C1'
p885
S'FOXA1'
p886
S'increases'
p887
tp888
(lp889
s(S'RAS family/GTP'
p890
S'RIN1'
p891
S'increases_activity'
p892
tp893
(lp894
s(S'COMPLEX (RAS/GTP/ RAF)'
p895
S'MEK'
p896
S'binds'
p897
tp898
(lp899
s(S'CDC5L'
p900
S'NRAS'
p901
S'increases'
p902
tp903
(lp904
s(S'Vitamin E'
p905
S'NRAS MRNA'
p906
S'decreases'
p907
tp908
(lp909
s(S'NF1'
p910
S'LEF1'
p911
S'increases'
p912
tp913
(lp914
s(S'ETS1'
p915
S'EN1'
p916
S'increases'
p917
tp918
(lp919
s(S'CRAF'
p920
S'YWHAB'
p921
S'binds'
p922
tp923
(lp924
s(S'CEBPD'
p925
S'JUN'
p926
S'increases'
p927
tp928
(lp929
s(S'MAX'
p930
S'RUNX2'
p931
S'increases'
p932
tp933
(lp934
s(S'CEBPA'
p935
S'MECOM'
p936
S'increases'
p937
tp938
(lp939
s(S'PAX2'
p940
S'GATA1'
p941
S'increases'
p942
tp943
(lp944
s(S'CYP26A1'
p945
S'TLX2'
p946
S'increases'
p947
tp948
(lp949
s(S'GFI1'
p950
S'ETS1'
p951
S'increases'
p952
tp953
(lp954
s(S'14-3-3:P-S259,Y340,Y341,S621-RAF1:RAS:GTP'
p955
S'MEK'
p956
S'binds'
p957
tp958
(lp959
s(S'P-S,T-MEK2'
p960
S'ERK2'
p961
S'binds'
p962
tp963
(lp964
s(S'HRAS/GTP'
p965
S'RIN2'
p966
S'increases_activity'
p967
tp968
(lp969
s(S'Ras-GTP'
p970
S'P42/P44MAPKS'
p971
S'adds_modification'
p972
tp973
(lp974
s(S'SRF'
p975
S'CYP26A1'
p976
S'increases'
p977
tp978
(lp979
s(S'FOXL1'
p980
S'RUNX2'
p981
S'increases'
p982
tp983
(lp984
s(S'EGR4'
p985
S'LEF1'
p986
S'increases'
p987
tp988
(lp989
s(S'P-IRS1,2'
p990
S'GRB2:SOS1'
p991
S'binds'
p992
tp993
(lp994
s(S'VEGFR2 (dimer)/VEGFA (dimer)/alphav/beta3 Integrin/Vitronectin'
p995
S'SRC'
p996
S'adds_modification'
p997
tp998
(lp999
s(S'BACH2'
p1000
S'BACH1'
p1001
S'increases'
p1002
tp1003
(lp1004
s(S'ONECUT1'
p1005
S'RUNX1'
p1006
S'increases'
p1007
tp1008
(lp1009
s(S'FOXJ2'
p1010
S'RUNX2'
p1011
S'increases'
p1012
tp1013
(lp1014
s(S'PI-3-4-5-P3'
p1015
S'AKT1'
p1016
S'translocates'
p1017
tp1018
(lp1019
s(S'TFAP4'
p1020
S'BACH1'
p1021
S'increases'
p1022
tp1023
(lp1024
s(S'MEKK1/4'
p1025
S'MKK3/6'
p1026
S'adds_modification'
p1027
tp1028
(lp1029
s(S'VSX1'
p1030
S'MECOM'
p1031
S'increases'
p1032
tp1033
(lp1034
s(S'IRF1'
p1035
S'GATA6'
p1036
S'increases'
p1037
tp1038
(lp1039
s(S'MAX'
p1040
S'HOXA9'
p1041
S'increases'
p1042
tp1043
(lp1044
s(S'RB1'
p1045
S'MAZ'
p1046
S'increases'
p1047
tp1048
(lp1049
S"FLAG-tagged-MAZ was expressed from the plasmid BRB112 in BL21 (DE3) pLysS cells (Invitrogen, Cedar Creek, TX, USA) according to the manufacturer's protocol."
p1050
aS'We investigated the role of MAZ in regulation of c-myb expression via transfection of the MAZ expression plasmid BRB112 in Flp-In 293 Myb WT reporter stable cells ('
p1051
aS'Transfection of the MAZ expression plasmid BRB112 into the Flp-In 293 Myb WT reporter stable cells.'
p1052
aS'We would like to thank Dr Linda Boxer at Stanford University School of Medicine and Dr Kelly Jordan-Sciutto at the University of Pennsylvania for providing the plasmid LB178 from which we obtained the c-myb promoter and the plasmid BRB112 that is used for expression of FLAG-MAZ, respectively.'
p1053
as(S'GATA1'
p1054
S'EN1'
p1055
S'increases'
p1056
tp1057
(lp1058
s(S'HIF1A'
p1059
S'SRF'
p1060
S'increases'
p1061
tp1062
(lp1063
s(S'IRF8'
p1064
S'CYP26A1'
p1065
S'increases'
p1066
tp1067
(lp1068
s(S'MTF1'
p1069
S'CYP26A1'
p1070
S'increases'
p1071
tp1072
(lp1073
s(S'PI-3-4-5-P3'
p1074
S'GAB1'
p1075
S'translocates'
p1076
tp1077
(lp1078
s(S'PI-3-4-5-P3'
p1079
S'AKT1'
p1080
S'adds_modification'
p1081
tp1082
(lp1083
s(S'RXRA'
p1084
S'HOXA9'
p1085
S'increases'
p1086
tp1087
(lp1088
s(S'AKT1'
p1089
S'RAF1'
p1090
S'binds'
p1091
tp1092
(lp1093
s(S'HSF2'
p1094
S'JUN'
p1095
S'increases'
p1096
tp1097
(lp1098
s(S'PAX2'
p1099
S'CYP26A1'
p1100
S'increases'
p1101
tp1102
(lp1103
s(S'ETV7'
p1104
S'CYP26A1'
p1105
S'increases'
p1106
tp1107
(lp1108
s(S'FOXO3'
p1109
S'NRAS'
p1110
S'increases'
p1111
tp1112
(lp1113
s(S'TP53'
p1114
S'REPIN1'
p1115
S'increases'
p1116
tp1117
(lp1118
s(S'STAT6'
p1119
S'CYP26A1'
p1120
S'increases'
p1121
tp1122
(lp1123
s(S'JUN'
p1124
S'NRAS'
p1125
S'increases'
p1126
tp1127
(lp1128
s(S'MYCN'
p1129
S'NRAS'
p1130
S'increases'
p1131
tp1132
(lp1133
s(S'STAT3'
p1134
S'YY1'
p1135
S'increases'
p1136
tp1137
(lp1138
s(S'Methyl Methanesulfonate'
p1139
S'HRAS MRNA'
p1140
S'increases'
p1141
tp1142
(lp1143
s(S'RHOA/GTP'
p1144
S'PKN'
p1145
S'increases_activity'
p1146
tp1147
(lp1148
s(S'NHLH1'
p1149
S'FOXJ2'
p1150
S'increases'
p1151
tp1152
(lp1153
s(S'RAS family/GTP'
p1154
S'BRAF'
p1155
S'adds_modification'
p1156
tp1157
(lp1158
s(S'RELA'
p1159
S'FOXJ2'
p1160
S'increases'
p1161
tp1162
(lp1163
s(S'TCF3'
p1164
S'RUNX1'
p1165
S'increases'
p1166
tp1167
(lp1168
s(S'FOXF2'
p1169
S'FOXO4'
p1170
S'increases'
p1171
tp1172
(lp1173
s(S'ATF4'
p1174
S'FOXD3'
p1175
S'increases'
p1176
tp1177
(lp1178
s(S'HAND1'
p1179
S'MECOM'
p1180
S'increases'
p1181
tp1182
(lp1183
s(S'RHOA/GTP'
p1184
S'P27KIP1'
p1185
S'adds_modification'
p1186
tp1187
(lp1188
s(S'SRF'
p1189
S'NRAS'
p1190
S'increases'
p1191
tp1192
(lp1193
s(S'ESRRA'
p1194
S'POU3F2'
p1195
S'increases'
p1196
tp1197
(lp1198
s(S'BRAF'
p1199
S'MEK1'
p1200
S'adds_modification'
p1201
tp1202
(lp1203
S'To assess whether reducing Cu binding in MEK1 affects BRAF'
p1204
aS'We next tested whether bypassing the requirement of MEK1/2 for Cu restores BRAF'
p1205
aS'While the detailed mechanism underlying the requirement of Cu for robust MEK1/2 kinase activity remains to be elucidated, we show that decreasing Cu influx, Cu bioavailability, and binding of Cu to MEK1 reduced MEK1(2) kinase activity and oncogenic BRAF-driven tumorigenesis.'
p1206
as(S'Cadmium Chloride'
p1207
S'KRAS PROTEIN'
p1208
S'increases'
p1209
tp1210
(lp1211
s(S'PRRX2'
p1212
S'MEIS1'
p1213
S'increases'
p1214
tp1215
(lp1216
s(S'MYC'
p1217
S'NRAS'
p1218
S'increases'
p1219
tp1220
(lp1221
S'KSRP knock-down increased mRNA levels of two let-7 targets, NRAS and MYC ('
p1222
as(S'MAZ'
p1223
S'KRAS'
p1224
S'increases'
p1225
tp1226
(lp1227
S'To explore the functional role played by MAZ within the KRAS transcription, we measured '
p1228
as(S'Rho Family GTPase-active'
p1229
S'PI3K'
p1230
S'increases_activity'
p1231
tp1232
(lp1233
s(S'STAT2'
p1234
S'CYP26A1'
p1235
S'increases'
p1236
tp1237
(lp1238
s(S'hsa-let-7a-5p'
p1239
S'KRAS'
p1240
S'decreases'
p1241
tp1242
(lp1243
s(S'POU3F2'
p1244
S'NRAS'
p1245
S'increases'
p1246
tp1247
(lp1248
s(S'SRF'
p1249
S'FOXO4'
p1250
S'increases'
p1251
tp1252
(lp1253
s(S'S1P1/Sphingosine-1-phosphate/PDGF-BB/PDGFRB (dimer)'
p1254
S'SRC FAMILY KINASES'
p1255
S'increases_activity'
p1256
tp1257
(lp1258
s(S'MYC/Max'
p1259
S'ERBB2'
p1260
S'decreases'
p1261
tp1262
(lp1263
s(S'SREBF1'
p1264
S'CBFA2T3'
p1265
S'increases'
p1266
tp1267
(lp1268
s(S'PI3K'
p1269
S'GELSOLIN/PI-3-4-5-P3'
p1270
S'binds'
p1271
tp1272
(lp1273
s(S'NHLH1'
p1274
S'EN1'
p1275
S'increases'
p1276
tp1277
(lp1278
s(S'LMO2'
p1279
S'GATA6'
p1280
S'increases'
p1281
tp1282
(lp1283
s(S'POU1F1'
p1284
S'FOXD3'
p1285
S'increases'
p1286
tp1287
(lp1288
s(S'hsa-miR-148b-3p'
p1289
S'NRAS'
p1290
S'decreases'
p1291
tp1292
(lp1293
s(S'Quercetin'
p1294
S'KRAS PROTEIN'
p1295
S'decreases'
p1296
tp1297
(lp1298
s(S'PAK2'
p1299
S'MEKK1'
p1300
S'adds_modification'
p1301
tp1302
(lp1303
s(S'LMO2'
p1304
S'MAZ'
p1305
S'increases'
p1306
tp1307
(lp1308
s(S'FOXO1'
p1309
S'POU3F2'
p1310
S'increases'
p1311
tp1312
(lp1313
s(S'NKX2-1'
p1314
S'MAZ'
p1315
S'increases'
p1316
tp1317
(lp1318
s(S'GRB2/SOS1'
p1319
S'PDGF-BB/PDGFRB (DIMER)/P52 SHC'
p1320
S'binds'
p1321
tp1322
(lp1323
s(S'PI3K'
p1324
S'CRK/P130 CAS/PAXILLIN'
p1325
S'increases_activity'
p1326
tp1327
(lp1328
s(S'ATF1'
p1329
S'FOXD3'
p1330
S'increases'
p1331
tp1332
(lp1333
s(S'GATA1'
p1334
S'SRF'
p1335
S'increases'
p1336
tp1337
(lp1338
s(S'TFAP2C'
p1339
S'CYP26A1'
p1340
S'increases'
p1341
tp1342
(lp1343
s(S'AHR'
p1344
S'MEIS1'
p1345
S'increases'
p1346
tp1347
(lp1348
s(S'ETS2'
p1349
S'CYP26A1'
p1350
S'increases'
p1351
tp1352
(lp1353
s(S'Estradiol'
p1354
S'NRAS MRNA'
p1355
S'increases'
p1356
tp1357
(lp1358
s(S'E2F1'
p1359
S'HOXA9'
p1360
S'increases'
p1361
tp1362
(lp1363
s(S'PDGF-BB/PDGFRB (DIMER)'
p1364
S'RASGAP'
p1365
S'binds'
p1366
tp1367
(lp1368
s(S'E2F1'
p1369
S'GABPB2'
p1370
S'increases'
p1371
tp1372
(lp1373
s(S'FOXJ1'
p1374
S'POU3F2'
p1375
S'increases'
p1376
tp1377
(lp1378
s(S'VSX1'
p1379
S'CYP26A1'
p1380
S'increases'
p1381
tp1382
(lp1383
s(S'SPI1'
p1384
S'CDC5L'
p1385
S'increases'
p1386
tp1387
(lp1388
s(S'Gi family'
p1389
S'HRAS/GDP'
p1390
S'increases_activity'
p1391
tp1392
(lp1393
s(S'TCF3'
p1394
S'CYP26A1'
p1395
S'increases'
p1396
tp1397
(lp1398
s(S'IGF-1R HETEROTETRAMER/IGF1/IRS1'
p1399
S'GRB2/SOS1'
p1400
S'binds'
p1401
tp1402
(lp1403
s(S'RAS family/GTP'
p1404
S'RALGDS'
p1405
S'translocates'
p1406
tp1407
(lp1408
s(S'PI3K'
p1409
S'RAC1/GDP'
p1410
S'increases_activity'
p1411
tp1412
(lp1413
s(S'Ca2+'
p1414
S'PKC'
p1415
S'increases_activity'
p1416
tp1417
(lp1418
S'The Ca2+-activated PKC Apl-I interacts with the PDZ domain protein '
p1419
as(S'ZIC1'
p1420
S'CYP26A1'
p1421
S'increases'
p1422
tp1423
(lp1424
s(S'IRF7'
p1425
S'TLX2'
p1426
S'increases'
p1427
tp1428
(lp1429
s(S'SHC/SHIP'
p1430
S'HRAS/GDP'
p1431
S'decreases_activity'
p1432
tp1433
(lp1434
s(S'hsa-let-7a-5p'
p1435
S'HRAS'
p1436
S'decreases'
p1437
tp1438
(lp1439
s(S'GATA4'
p1440
S'MAZ'
p1441
S'increases'
p1442
tp1443
(lp1444
s(S'EN1'
p1445
S'NRAS'
p1446
S'increases'
p1447
tp1448
(lp1449
s(S'PI3K'
p1450
S'BAM32'
p1451
S'adds_modification'
p1452
tp1453
(lp1454
s(S'GABPB1'
p1455
S'CYP26A1'
p1456
S'increases'
p1457
tp1458
(lp1459
s(S'Trifluoroethanol'
p1460
S'HRAS'
p1461
S'increases_activity'
p1462
tp1463
(lp1464
s(S'SOX5'
p1465
S'CYP26A1'
p1466
S'increases'
p1467
tp1468
(lp1469
s(S'GRB2/SOS1'
p1470
S'HGF(DIMER)/MET(DIMER)/P52 SHC'
p1471
S'binds'
p1472
tp1473
(lp1474
s(S'TCF12'
p1475
S'EN1'
p1476
S'increases'
p1477
tp1478
(lp1479
s(S'SOX9'
p1480
S'MEIS1'
p1481
S'increases'
p1482
tp1483
(lp1484
s(S'RB1'
p1485
S'MYC'
p1486
S'increases'
p1487
tp1488
(lp1489
S'The Proliferative group showed a decrease in the rate of MYC amplification and RB1 deletion, whereas the Immunoreactive subtype showed an increased frequency of 3q26.2 (MECOM) amplification ('
p1490
as(S'RXRA'
p1491
S'FOXA1'
p1492
S'increases'
p1493
tp1494
(lp1495
S'Also, the TF table shows as significantly enriched a series of TFs (HNF4A, HNF4G, RXRA, FOXA1, and so on) known to be associated with tissue-specific gene expression in liver or liver development.'
p1496
aS'Human liver-enriched TRFs used in Matrix RNAi are as follows: HNF1A (TCF1), HNF1B (TCF2), HNF3A (FOXA1), HNF3B (FOXA2), HNF3G (FOXA3), HNF4A, HNF4G, HNF6A (ONECUT1), CEBPA, CEBPB, CEBPD, PPARA, PPARD, PPARG, RARA, RARB, RARG, RXRA, RXRB, RXRG, RORA and RORC.'
p1497
aS'For this purpose, we knocked down each of the three selected TRFs (FOXA1, ONECUT1 and RXRA) with two discrete siRNAs that targeted different sites in each of the TRF mRNAs.'
p1498
as(S'decitabine'
p1499
S'HRAS MRNA'
p1500
S'decreases'
p1501
tp1502
(lp1503
s(S'VSX1'
p1504
S'EN1'
p1505
S'increases'
p1506
tp1507
(lp1508
s(S'FOXL1'
p1509
S'CYP26A1'
p1510
S'increases'
p1511
tp1512
(lp1513
s(S'PAX2'
p1514
S'RUNX1'
p1515
S'increases'
p1516
tp1517
(lp1518
s(S'MEKK1/4'
p1519
S'MKK4/7'
p1520
S'adds_modification'
p1521
tp1522
(lp1523
s(S'HOXA9'
p1524
S'CYP26A1'
p1525
S'increases'
p1526
tp1527
(lp1528
s(S'TRKC'
p1529
S'NT3 (DIMER)'
p1530
S'binds'
p1531
tp1532
(lp1533
s(S'PTF1A'
p1534
S'REPIN1'
p1535
S'increases'
p1536
tp1537
(lp1538
s(S'TGIF'
p1539
S'CYP26A1'
p1540
S'increases'
p1541
tp1542
(lp1543
s(S'MYOD1'
p1544
S'MYC'
p1545
S'increases'
p1546
tp1547
(lp1548
s(S'PKCT'
p1549
S'KRAS ISO2'
p1550
S'adds_modification'
p1551
tp1552
(lp1553
s(S'RAS family/GTP'
p1554
S'BRAF'
p1555
S'increases_activity'
p1556
tp1557
(lp1558
s(S'SPZ1'
p1559
S'CYP26A1'
p1560
S'increases'
p1561
tp1562
(lp1563
s(S'HRAS/GTP'
p1564
S'GALECTIN-1'
p1565
S'binds'
p1566
tp1567
(lp1568
s(S'DBP'
p1569
S'FOXD3'
p1570
S'increases'
p1571
tp1572
(lp1573
s(S'E2F1'
p1574
S'POU2F1'
p1575
S'increases'
p1576
tp1577
(lp1578
s(S'MEIS1'
p1579
S'CYP26A1'
p1580
S'increases'
p1581
tp1582
(lp1583
s(S'YY1'
p1584
S'NRAS'
p1585
S'increases'
p1586
tp1587
(lp1588
s(S'RAS:RAF'
p1589
S'YWHAB'
p1590
S'binds'
p1591
tp1592
(lp1593
s(S'NFE2L2'
p1594
S'CYP26A1'
p1595
S'increases'
p1596
tp1597
(lp1598
s(S'FARNESYL'
p1599
S'KRAS'
p1600
S'increases_activity'
p1601
tp1602
(lp1603
s(S'MTF1'
p1604
S'MECOM'
p1605
S'increases'
p1606
tp1607
(lp1608
s(S'TLX2'
p1609
S'FOXD3'
p1610
S'increases'
p1611
tp1612
(lp1613
s(S'Insulin Receptor/Insulin/SHC/GRB2/Sos1'
p1614
S'HRAS/GDP'
p1615
S'increases_activity'
p1616
tp1617
(lp1618
s(S'MYC'
p1619
S'ELK1'
p1620
S'increases'
p1621
tp1622
(lp1623
s(S'ONECUT1'
p1624
S'POU2F1'
p1625
S'increases'
p1626
tp1627
(lp1628
s(S'Paraquat'
p1629
S'HRAS MRNA'
p1630
S'translocates'
p1631
tp1632
(lp1633
s(S'GRB2/SOS1'
p1634
S'PDGF-BB/PDGFRB (DIMER)/SHP2'
p1635
S'binds'
p1636
tp1637
(lp1638
s(S'ONECUT1'
p1639
S'CYP26A1'
p1640
S'increases'
p1641
tp1642
(lp1643
s(S'MYC'
p1644
S'FOXO3'
p1645
S'increases'
p1646
tp1647
(lp1648
s(S'PAX3'
p1649
S'ELK1'
p1650
S'increases'
p1651
tp1652
(lp1653
s(S'DOK-R'
p1654
S'RASGAP'
p1655
S'binds'
p1656
tp1657
(lp1658
s(S'HOXA4'
p1659
S'HOXA9'
p1660
S'increases'
p1661
tp1662
(lp1663
s(S'MAX'
p1664
S'POU3F2'
p1665
S'increases'
p1666
tp1667
(lp1668
s(S'Estradiol'
p1669
S'KRAS MRNA'
p1670
S'decreases'
p1671
tp1672
(lp1673
s(S'KRAS ISOFORM 4B/GTP'
p1674
S'CAM/CA2+'
p1675
S'binds'
p1676
tp1677
(lp1678
s(S'MAZ'
p1679
S'FOXO4'
p1680
S'increases'
p1681
tp1682
(lp1683
g205
as(S'hsa-miR-181a-5p'
p1684
S'KRAS'
p1685
S'decreases'
p1686
tp1687
(lp1688
s(S'GATA1'
p1689
S'CYP26A1'
p1690
S'increases'
p1691
tp1692
(lp1693
s(S'PGR'
p1694
S'ETS1'
p1695
S'increases'
p1696
tp1697
(lp1698
s(S'GATA1'
p1699
S'POU2F1'
p1700
S'increases'
p1701
tp1702
(lp1703
s(S'BRAF'
p1704
S'MEK1-2'
p1705
S'increases_activity'
p1706
tp1707
(lp1708
s(S'LEF1'
p1709
S'GABPB2'
p1710
S'increases'
p1711
tp1712
(lp1713
s(S'CYP26A1'
p1714
S'MYC'
p1715
S'increases'
p1716
tp1717
(lp1718
s(S'STAT1'
p1719
S'IRF1'
p1720
S'increases'
p1721
tp1722
(lp1723
s(S'SMAD1'
p1724
S'RUNX2'
p1725
S'increases'
p1726
tp1727
(lp1728
s(S'ZEB1'
p1729
S'TLX2'
p1730
S'increases'
p1731
tp1732
(lp1733
s(S'STAT5B'
p1734
S'IRF1'
p1735
S'increases'
p1736
tp1737
(lp1738
s(S'POU6F1'
p1739
S'CYP26A1'
p1740
S'increases'
p1741
tp1742
(lp1743
s(S'Vincristine'
p1744
S'HRAS MRNA'
p1745
S'increases'
p1746
tp1747
(lp1748
s(S'DAG'
p1749
S'RASGRP1'
p1750
S'adds_modification'
p1751
tp1752
(lp1753
s(S'PI3K'
p1754
S'PDK1'
p1755
S'increases_activity'
p1756
tp1757
(lp1758
S'Phosphoinositide-dependent kinase 1 (PDK1, A001740), a pleckstrin-homology domain (PH-domain) containing protein kinase, is a well-characterized downstream effector of PI3K that has been suggested to act as a master regulator of the protein kinase A-protein kinase G-protein kinase C (AGC) family of kinases'
p1759
aS'In differentiated myofibres, Wnt7a binds to Fzd7 resulting in the activation of PI3K, which in turn activates phosphatidyl inositol-dependent kinase1 (PDK1).'
p1760
aS'PTEN: phosphatase and tensin homolog; mTORC1: mammalian target of rapamycin complex 1; CNS: central nervous system; 4E-BP: eukaryotic translation initiation factor 4E-binding protein; S6K: S6 kinase; PI3K: phosphatidylinositol 3-kinase; RTK: receptor tyrosine kinase; IRS-1: insulin receptor substrate 1; PDK1: phosphoinositide-dependent kinase-1; TSC: tuberous sclerosis.'
p1761
aS'PI3K generates phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3), leading to a cascade of signalling events, including the recruitment and activation/inactivation of several kinases, such as PDK1, AKT, and GSK3.'
p1762
aS'It is worth noting that in addition to the well-known kinases such as AKTs and PDK1 involved in the canonical PI3K signaling, there are six different kinases also containing the pleckstrin homology (PH) domain that can bind to phosphatidylinositol 3,4,5-trisphosphate (PIP3).'
p1763
aS'GHSR1a = GH secretagogue receptor 1a; CaMKK2 = calmodulin kinase kinase 2; AMPK = AMP-activated protein kinase; JAK2 = janus kinase 2; IRS = insulin receptor substrate; PI3K = phosphoinositide 3-kinase; PDK1 = phospholipid-dependent kinase 1; PKB = protein kinase B; TSC1/2 = tuberous sclerosis complex 1 (hamartin) and 2 (tuberin); Rheb = Ras homolog enriched in brain.'
p1764
as(S'ETS2'
p1765
S'PAX4'
p1766
S'increases'
p1767
tp1768
(lp1769
s(S'NR3C1'
p1770
S'ONECUT1'
p1771
S'increases'
p1772
tp1773
(lp1774
s(S'CUX1'
p1775
S'CYP26A1'
p1776
S'increases'
p1777
tp1778
(lp1779
s(S'ZEB1'
p1780
S'GATA1'
p1781
S'increases'
p1782
tp1783
(lp1784
s(S'NRF1'
p1785
S'POU2F1'
p1786
S'increases'
p1787
tp1788
(lp1789
s(S'FOXJ2'
p1790
S'MECOM'
p1791
S'increases'
p1792
tp1793
(lp1794
s(S'MAZ'
p1795
S'MYCN'
p1796
S'increases'
p1797
tp1798
(lp1799
s(S'Hydrogen Peroxide'
p1800
S'HRAS MRNA'
p1801
S'increases'
p1802
tp1803
(lp1804
s(S'RASA1'
p1805
S'P-EPHBS:EFNBS'
p1806
S'binds'
p1807
tp1808
(lp1809
s(S'SPI1'
p1810
S'CEBPG'
p1811
S'increases'
p1812
tp1813
(lp1814
s(S'EGR1'
p1815
S'LEF1'
p1816
S'increases'
p1817
tp1818
(lp1819
s(S'RET51/GFRALPHA1/GDNF'
p1820
S'P62DOK'
p1821
S'binds'
p1822
tp1823
(lp1824
s(S'TFDP2'
p1825
S'CYP26A1'
p1826
S'increases'
p1827
tp1828
(lp1829
s(S'matrine'
p1830
S'NRAS MRNA'
p1831
S'increases'
p1832
tp1833
(lp1834
s(S'Isotretinoin'
p1835
S'KRAS MRNA'
p1836
S'decreases'
p1837
tp1838
(lp1839
s(S'PITX2'
p1840
S'FOXF2'
p1841
S'increases'
p1842
tp1843
(lp1844
s(S'MYOD1'
p1845
S'POU2F1'
p1846
S'increases'
p1847
tp1848
(lp1849
s(S'sodium arsenite'
p1850
S'KRAS PROTEIN'
p1851
S'increases'
p1852
tp1853
(lp1854
s(S'TCF4'
p1855
S'CBFA2T3'
p1856
S'increases'
p1857
tp1858
(lp1859
s(S'CYP26A1'
p1860
S'FOXA1'
p1861
S'increases'
p1862
tp1863
(lp1864
s(S'TP53'
p1865
S'CYP26A1'
p1866
S'increases'
p1867
tp1868
(lp1869
s(S'ATF3'
p1870
S'FOXD3'
p1871
S'increases'
p1872
tp1873
(lp1874
s(S'POU2F1'
p1875
S'NRAS'
p1876
S'increases'
p1877
tp1878
(lp1879
s(S'NRF1'
p1880
S'GABPB2'
p1881
S'increases'
p1882
tp1883
(lp1884
s(S'PAX4'
p1885
S'TLX2'
p1886
S'increases'
p1887
tp1888
(lp1889
s(S'PITX2'
p1890
S'FOXA1'
p1891
S'increases'
p1892
tp1893
(lp1894
s(S'GTF3A'
p1895
S'POU2F1'
p1896
S'increases'
p1897
tp1898
(lp1899
s(S'HLF'
p1900
S'FOXO3'
p1901
S'increases'
p1902
tp1903
(lp1904
s(S'PAX4'
p1905
S'FOXO4'
p1906
S'increases'
p1907
tp1908
(lp1909
s(S'CEBPA'
p1910
S'FOXD3'
p1911
S'increases'
p1912
tp1913
(lp1914
s(S'NFE2'
p1915
S'CYP26A1'
p1916
S'increases'
p1917
tp1918
(lp1919
s(S'MYB'
p1920
S'GABPB2'
p1921
S'increases'
p1922
tp1923
(lp1924
s(S'MYC'
p1925
S'CEBPA'
p1926
S'increases'
p1927
tp1928
(lp1929
s(S'ELK1'
p1930
S'EN1'
p1931
S'increases'
p1932
tp1933
(lp1934
s(S'E2F1'
p1935
S'CDC5L'
p1936
S'increases'
p1937
tp1938
(lp1939
s(S'YWHAZ (DIMER)'
p1940
S'RAF1'
p1941
S'binds'
p1942
tp1943
(lp1944
s(S'ATF6'
p1945
S'CYP26A1'
p1946
S'increases'
p1947
tp1948
(lp1949
s(S'sodium arsenite'
p1950
S'HRAS MRNA'
p1951
S'increases'
p1952
tp1953
(lp1954
s(S'EGR3'
p1955
S'CYP26A1'
p1956
S'increases'
p1957
tp1958
(lp1959
s(S'lead acetate'
p1960
S'HRAS PROTEIN'
p1961
S'increases_activity'
p1962
tp1963
(lp1964
s(S'REPIN1'
p1965
S'MYC'
p1966
S'increases'
p1967
tp1968
(lp1969
s(S'CEBPA'
p1970
S'NRAS'
p1971
S'increases'
p1972
tp1973
(lp1974
s(S'Quercetin'
p1975
S'NRAS MRNA'
p1976
S'decreases'
p1977
tp1978
(lp1979
s(S'14-3-3 E'
p1980
S'TERT'
p1981
S'binds'
p1982
tp1983
(lp1984
s(S'Antigen/IgE/Fc epsilon R1/LYN/SYK'
p1985
S'BTK'
p1986
S'adds_modification'
p1987
tp1988
(lp1989
s(S'HSF2'
p1990
S'CBFA2T3'
p1991
S'increases'
p1992
tp1993
(lp1994
s(S'Fluorouracil'
p1995
S'HRAS MRNA'
p1996
S'increases'
p1997
tp1998
(lp1999
s(S'STAT4'
p2000
S'MECOM'
p2001
S'increases'
p2002
tp2003
(lp2004
s(S'ETS2'
p2005
S'ETS1'
p2006
S'increases'
p2007
tp2008
(lp2009
S'Interestingly, the occupancy of UBF to UCE, CORE, ENH, ETS1, ETS2 and ETS3 regions of the rDNA promoter was markedly increased in ESET ON cells compared with control cells without ESET induction ('
p2010
aS'When overexpressed, the ETS proteins ETS1, ETS2 and ETV1 can activate ETS/AP-1 regulated reporter genes ('
p2011
as(S'CEBPG'
p2012
S'CYP26A1'
p2013
S'increases'
p2014
tp2015
(lp2016
s(S'Complex (PDGF receptor A/PDGF receptor B)'
p2017
S'NCK'
p2018
S'adds_modification'
p2019
tp2020
(lp2021
s(S'Fog1'
p2022
S'MYB'
p2023
S'decreases'
p2024
tp2025
(lp2026
s(S'CREB1'
p2027
S'FOXD3'
p2028
S'increases'
p2029
tp2030
(lp2031
s(S'Numb'
p2032
S'NICS'
p2033
S'translocates'
p2034
tp2035
(lp2036
s(S'STAT6'
p2037
S'STAT5A'
p2038
S'increases'
p2039
tp2040
(lp2041
g839
as(S'RAF1/14-3-3'
p2042
S'BRAF/14-3-3'
p2043
S'binds'
p2044
tp2045
(lp2046
s(S'B-cell antigen/BCR complex/LYN/SYK/BLNK'
p2047
S'SHC/GRB2/SOS1'
p2048
S'increases_activity'
p2049
tp2050
(lp2051
s(S'IRF2'
p2052
S'CYP26A1'
p2053
S'increases'
p2054
tp2055
(lp2056
s(S'GATA6'
p2057
S'CYP26A1'
p2058
S'increases'
p2059
tp2060
(lp2061
s(S'HMGA1'
p2062
S'CYP26A1'
p2063
S'increases'
p2064
tp2065
(lp2066
s(S'MTF1'
p2067
S'FOXO4'
p2068
S'increases'
p2069
tp2070
(lp2071
s(S'STAT1'
p2072
S'GABPB2'
p2073
S'increases'
p2074
tp2075
(lp2076
s(S'manumycin'
p2077
S'HRAS PROTEIN'
p2078
S'decreases'
p2079
tp2080
(lp2081
s(S'STAT5A'
p2082
S'ETS1'
p2083
S'increases'
p2084
tp2085
(lp2086
s(S'SPI1'
p2087
S'CBFA2T3'
p2088
S'increases'
p2089
tp2090
(lp2091
s(S'GMCSF/GMR ALPHA/CSF2RB/JAK2 (DODECAMER)/SHC'
p2092
S'GRB2/SOS1'
p2093
S'binds'
p2094
tp2095
(lp2096
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2097
S'NRAS PROTEIN'
p2098
S'increases'
p2099
tp2100
(lp2101
s(S'CDC5L'
p2102
S'CYP26A1'
p2103
S'increases'
p2104
tp2105
(lp2106
s(S'PAX4'
p2107
S'POU3F2'
p2108
S'increases'
p2109
tp2110
(lp2111
s(S'SPRED2'
p2112
S'HRAS'
p2113
S'binds'
p2114
tp2115
(lp2116
s(S'PITX2'
p2117
S'FOXO4'
p2118
S'increases'
p2119
tp2120
(lp2121
s(S'FOXD3'
p2122
S'CYP26A1'
p2123
S'increases'
p2124
tp2125
(lp2126
s(S'NFIL3'
p2127
S'FOXO3'
p2128
S'increases'
p2129
tp2130
(lp2131
s(S'MTF1'
p2132
S'POU2F1'
p2133
S'increases'
p2134
tp2135
(lp2136
s(S'TFCP2'
p2137
S'BACH1'
p2138
S'increases'
p2139
tp2140
(lp2141
s(S'NF1'
p2142
S'MECOM'
p2143
S'increases'
p2144
tp2145
(lp2146
s(S'FOXO3'
p2147
S'FOXD3'
p2148
S'increases'
p2149
tp2150
(lp2151
s(S'STAT5A'
p2152
S'TLX2'
p2153
S'increases'
p2154
tp2155
(lp2156
s(S'RIN1'
p2157
S'HRAS/GTP'
p2158
S'adds_modification'
p2159
tp2160
(lp2161
s(S'STAT5A'
p2162
S'CEBPG'
p2163
S'increases'
p2164
tp2165
(lp2166
s(S'DAG'
p2167
S'PKC'
p2168
S'increases_activity'
p2169
tp2170
(lp2171
S'Taken together, these results indicate that an ordered cascade of nPKCs functions downstream of DAG to promote MTOC reorientation in T cells.'
p2172
aS'Given the importance of synaptically localized DAG for MTOC reorientation, we hypothesized that nPKCs, which contain high affinity C1 domains, would be recruited to the IS and play a role in the polarization response.'
p2173
aS'DAG binding by nPKCs is mediated by the tandem C1 domains located N-terminal to the kinase domain'
p2174
aS'We next tested whether PLC, a downstream target of RTK signaling, was also activated in a polarized fashion, using an improved DAG sensor to monitor whether PLC-generated DAG was polarized in migrating cells (PKC'
p2175
aS'Since protein kinase C (PKC) is a main intracellular target of DAG and since PKCs have a role in regulating actin polymerization by phosphorylating actin regulators such as MARCKS, adducin, fascin, and ERM proteins'
p2176
aS'ER: Estrogen receptor; IP3: inositol-trisphosphate; DAG: diacyl glycerol; PKC: protein kinase C; MEK: mitogen-activated protein kinase/extracellular-signal-regulated kinase kinase; RSK: ribosomal S6 kinase; GAB1: Grb2-associated binder-1; CaMKK: Ca'
p2177
aS'The activation of cPKCs requires diacylglycerol (DAG) as an activator and phosphatidylserine (PS) and Ca'
p2178
aS'Unlike chimaerins, DAG-regulated PKCs contain two C1 domains in tandem (C1a and C1b).'
p2179
aS'The 3 isoforms, PRKD1, PRKD2, and PRKD3, contain highly conserved structural motifs within their regulatory domains and are directly activated by phorbolesters, diacylglycerol (DAG), or DAG-activated protein kinase C (PKC) isoforms.'
p2180
aS'Unexpectedly, DAG-induced ATP release was found to be independent of PKC activation, but dependent upon activation of a C1 domain-containing protein.'
p2181
aS'The inhibition of calcium oscillations by calphostin C suggests that astrocytic ATP release is mediated via a DAG-binding protein other than PKC.'
p2182
aS'I have shown, using in vitro live imaging, that stimulation of the DAG pathway with the DAG analogue, OAG, results in ATP release that appears to be both PKC independent and vesicular.'
p2183
aS'DAG activation of PKC has long been known to potentiate synaptic function    ['
p2184
aS'A potential role of DAG will be discussed further below in the context of a role for PKC.'
p2185
aS'PKC is physiologically activated by DAG, and this can occur subsequent to stimulation of PI-PLC, PC-PLC or PLD (see above) and, in some types of smooth muscle, may contribute to the sustained phase of contraction (Aburto et al. '
p2186
as(S'HNF4A'
p2187
S'FOXA1'
p2188
S'increases'
p2189
tp2190
(lp2191
S'This approach led to detection of both known and/or novel combinatorial regulatory sites, which were targeted by several liver-enriched TRFs [HNF1A, HNF3A (FOXA1, HGNC symbol), HNF3B (FOXA2), HNF3G (FOXA3) and HNF4A] in the three liver-enriched TRF genes, HNF1A, CEBPA and HNF3G.'
p2192
aS'As an example, one of deSNPs, rs17744121, overlaps ChIP-seq peaks of HNF4A and FOXA1 (Figure '
p2193
ag1496
ag1497
as(S'LEF1'
p2194
S'MAZ'
p2195
S'increases'
p2196
tp2197
(lp2198
s(S'hsa-miR-124-3p'
p2199
S'NRAS'
p2200
S'decreases'
p2201
tp2202
(lp2203
s(S'RAF1'
p2204
S'14-3-3 E'
p2205
S'binds'
p2206
tp2207
(lp2208
s(S'GATA1'
p2209
S'MYB'
p2210
S'decreases'
p2211
tp2212
(lp2213
s(S'LMO2'
p2214
S'GATA1'
p2215
S'increases'
p2216
tp2217
(lp2218
S'Finally, CEG33 genes that are characterized by expression peaking in erythroblasts, and the putative regulators GATA1 and LMO2, identified according with motif discovery results, were mapped on Biocarta pathways.'
p2219
as(S'HRAS/GTP'
p2220
S'RAF1'
p2221
S'increases_activity'
p2222
tp2223
(lp2224
s(S'MYCN'
p2225
S'RUNX2'
p2226
S'increases'
p2227
tp2228
(lp2229
s(S'STAT5B'
p2230
S'CYP26A1'
p2231
S'increases'
p2232
tp2233
(lp2234
s(S'ZIC2'
p2235
S'MYCN'
p2236
S'increases'
p2237
tp2238
(lp2239
s(S'FOXL1'
p2240
S'FOXD3'
p2241
S'increases'
p2242
tp2243
(lp2244
s(S'ZBTB18'
p2245
S'CBFA2T3'
p2246
S'increases'
p2247
tp2248
(lp2249
s(S'HSF1'
p2250
S'IRF1'
p2251
S'increases'
p2252
tp2253
(lp2254
s(S'SPZ1'
p2255
S'MAZ'
p2256
S'increases'
p2257
tp2258
(lp2259
s(S'SRY'
p2260
S'CYP26A1'
p2261
S'increases'
p2262
tp2263
(lp2264
s(S'FOXO4'
p2265
S'HOXA9'
p2266
S'increases'
p2267
tp2268
(lp2269
s(S'IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos'
p2270
S'HRAS/GDP'
p2271
S'increases_activity'
p2272
tp2273
(lp2274
s(S'hsa-miR-615-3p'
p2275
S'HRAS'
p2276
S'decreases'
p2277
tp2278
(lp2279
s(S'ESRRA'
p2280
S'FOXD3'
p2281
S'increases'
p2282
tp2283
(lp2284
s(S'ELK1'
p2285
S'CYP26A1'
p2286
S'increases'
p2287
tp2288
(lp2289
s(S'Hexane-1,6-Diol'
p2290
S'HRAS'
p2291
S'increases_activity'
p2292
tp2293
(lp2294
s(S'MAZ'
p2295
S'NRAS'
p2296
S'increases'
p2297
tp2298
(lp2299
s(S'MIF'
p2300
S'CYP26A1'
p2301
S'increases'
p2302
tp2303
(lp2304
s(S'AHR'
p2305
S'POU2F1'
p2306
S'increases'
p2307
tp2308
(lp2309
s(S'SMAD3'
p2310
S'CYP26A1'
p2311
S'increases'
p2312
tp2313
(lp2314
s(S'PI-3-4-5-P3'
p2315
S'GELSOLIN'
p2316
S'binds'
p2317
tp2318
(lp2319
s(S'ADP'
p2320
S'P-S724-IRE1 DIMER'
p2321
S'binds'
p2322
tp2323
(lp2324
s(S'testosterone enanthate'
p2325
S'KRAS MRNA'
p2326
S'increases'
p2327
tp2328
(lp2329
s(S'CYP26A1'
p2330
S'ONECUT1'
p2331
S'increases'
p2332
tp2333
(lp2334
s(S'Valproic Acid'
p2335
S'NRAS MRNA'
p2336
S'decreases'
p2337
tp2338
(lp2339
s(S'GTF2A2'
p2340
S'CYP26A1'
p2341
S'increases'
p2342
tp2343
(lp2344
s(S'CEBPA'
p2345
S'FOXO3'
p2346
S'increases'
p2347
tp2348
(lp2349
s(S'GATA3'
p2350
S'POU2F1'
p2351
S'increases'
p2352
tp2353
(lp2354
s(S'PI3K'
p2355
S'RAC1B/GDP'
p2356
S'increases_activity'
p2357
tp2358
(lp2359
s(S'CDC25C'
p2360
S'YWHAB'
p2361
S'binds'
p2362
tp2363
(lp2364
s(S'RAC1/GTP'
p2365
S'PAK1/BETAPIX/PKL/NCK1-2'
p2366
S'increases_activity'
p2367
tp2368
(lp2369
s(S'SMAD1'
p2370
S'CYP26A1'
p2371
S'increases'
p2372
tp2373
(lp2374
s(S'PI3K'
p2375
S'FAK'
p2376
S'adds_modification'
p2377
tp2378
(lp2379
S'We further investigated the role of phosphatidylinositol-3 kinase (PI3K) as well as the MAP kinase Erk1/2 pathway, both of which signal downstream of FAK, during PilA-mediated immune activation and cellular invasion.'
p2380
as(S'NRF1'
p2381
S'MAX'
p2382
S'increases'
p2383
tp2384
(lp2385
s(S'FOXI1'
p2386
S'RUNX2'
p2387
S'increases'
p2388
tp2389
(lp2390
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2391
S'HRAS MRNA'
p2392
S'increases'
p2393
tp2394
(lp2395
s(S'ETS1'
p2396
S'CBFA2T3'
p2397
S'increases'
p2398
tp2399
(lp2400
s(S'hsa-miR-98-5p'
p2401
S'NRAS'
p2402
S'decreases'
p2403
tp2404
(lp2405
s(S'PHOSPHORYLATED BRF1 (SER92, SER203):MRNA COMPLEX'
p2406
S'YWHAB'
p2407
S'binds'
p2408
tp2409
(lp2410
s(S'LMO2'
p2411
S'CYP26A1'
p2412
S'increases'
p2413
tp2414
(lp2415
s(S'SOS1'
p2416
S'GRB2:PFAK BOUND TO NCAM1:PFYN'
p2417
S'binds'
p2418
tp2419
(lp2420
s(S'GTF3A'
p2421
S'GATA6'
p2422
S'increases'
p2423
tp2424
(lp2425
s(S'ZIC2'
p2426
S'CYP26A1'
p2427
S'increases'
p2428
tp2429
(lp2430
s(S'PAX2'
p2431
S'POU3F2'
p2432
S'increases'
p2433
tp2434
(lp2435
s(S'CEBPD'
p2436
S'FOXO3'
p2437
S'increases'
p2438
tp2439
(lp2440
s(S'NF1'
p2441
S'CYP26A1'
p2442
S'increases'
p2443
tp2444
(lp2445
s(S'BRAF'
p2446
S'MEK2'
p2447
S'adds_modification'
p2448
tp2449
(lp2450
s(S'TFAP4'
p2451
S'RUNX1'
p2452
S'increases'
p2453
tp2454
(lp2455
s(S'FAK'
p2456
S'SOS'
p2457
S'binds'
p2458
tp2459
(lp2460
S'FAK activation by integrins regulates various cellular processes, and in many cases can be accounted for by an activation of Ras through the recruitment of the GRB2-SOS complex ['
p2461
as(S'EGR1'
p2462
S'RUNX1'
p2463
S'increases'
p2464
tp2465
(lp2466
s(S'TCF4'
p2467
S'FOXO4'
p2468
S'increases'
p2469
tp2470
(lp2471
s(S'MAZ'
p2472
S'CBFA2T3'
p2473
S'increases'
p2474
tp2475
(lp2476
s(S'MEIS1'
p2477
S'HRAS'
p2478
S'increases'
p2479
tp2480
(lp2481
s(S'RELA'
p2482
S'CYP26A1'
p2483
S'increases'
p2484
tp2485
(lp2486
s(S'hsa-miR-877-3p'
p2487
S'NRAS'
p2488
S'decreases'
p2489
tp2490
(lp2491
s(S'MYC'
p2492
S'LEF1'
p2493
S'increases'
p2494
tp2495
(lp2496
S'In contrast to the MYC or PTEN mRNAs, no significant enrichment of rare codons was observed in the coding region of LEF1 mRNAs (data not shown).'
p2497
as(S'FOXO4'
p2498
S'RUNX1'
p2499
S'increases'
p2500
tp2501
(lp2502
s(S'LEF1'
p2503
S'RUNX1'
p2504
S'increases'
p2505
tp2506
(lp2507
s(S'TFDP2'
p2508
S'GATA1'
p2509
S'increases'
p2510
tp2511
(lp2512
s(S'AHR'
p2513
S'CYP26A1'
p2514
S'increases'
p2515
tp2516
(lp2517
s(S'4-Nitroquinoline-1-oxide'
p2518
S'PTGS2 MRNA'
p2519
S'increases'
p2520
tp2521
(lp2522
s(S'TGIF'
p2523
S'FOXO3'
p2524
S'increases'
p2525
tp2526
(lp2527
s(S'FOXF2'
p2528
S'CEBPA'
p2529
S'increases'
p2530
tp2531
(lp2532
s(S'NFE2L1'
p2533
S'POU2F1'
p2534
S'increases'
p2535
tp2536
(lp2537
s(S'LHX3'
p2538
S'CYP26A1'
p2539
S'increases'
p2540
tp2541
(lp2542
s(S'HMGA1'
p2543
S'MEIS1'
p2544
S'increases'
p2545
tp2546
(lp2547
s(S'POU2F1'
p2548
S'CYP26A1'
p2549
S'increases'
p2550
tp2551
(lp2552
s(S'PRRX2'
p2553
S'HOXA9'
p2554
S'increases'
p2555
tp2556
(lp2557
s(S'ETS2'
p2558
S'CEBPG'
p2559
S'increases'
p2560
tp2561
(lp2562
s(S'hsa-miR-193b-3p'
p2563
S'KRAS'
p2564
S'decreases'
p2565
tp2566
(lp2567
s(S'RREB1'
p2568
S'RUNX1'
p2569
S'increases'
p2570
tp2571
(lp2572
s(S'IL2/IL2R BETA/GAMMA/JAK1/FYN/JAK3'
p2573
S'PI3K'
p2574
S'binds'
p2575
tp2576
(lp2577
s(S'ELK1'
p2578
S'MEIS1'
p2579
S'increases'
p2580
tp2581
(lp2582
s(S'CYP26A1'
p2583
S'HOXA9'
p2584
S'increases'
p2585
tp2586
(lp2587
s(S'SPZ1'
p2588
S'HOXA9'
p2589
S'increases'
p2590
tp2591
(lp2592
s(S'ERK1'
p2593
S'P-S218,222-MEK1'
p2594
S'binds'
p2595
tp2596
(lp2597
s(S'NHLH1'
p2598
S'MYC'
p2599
S'increases'
p2600
tp2601
(lp2602
s(S'Daunorubicin'
p2603
S'NRAS MRNA'
p2604
S'increases'
p2605
tp2606
(lp2607
s(S'HNF1A'
p2608
S'FOXA1'
p2609
S'increases'
p2610
tp2611
(lp2612
g2192
ag1497
as(S'MYC'
p2613
S'ONECUT1'
p2614
S'increases'
p2615
tp2616
(lp2617
s(S'Vanadates'
p2618
S'HRAS PROTEIN'
p2619
S'increases'
p2620
tp2621
(lp2622
s(S'Purine nucleotide'
p2623
S'H+'
p2624
S'translocates'
p2625
tp2626
(lp2627
s(S'NFE2'
p2628
S'BACH1'
p2629
S'increases'
p2630
tp2631
(lp2632
s(S'EGR4'
p2633
S'CYP26A1'
p2634
S'increases'
p2635
tp2636
(lp2637
s(S'NRF1'
p2638
S'ONECUT1'
p2639
S'increases'
p2640
tp2641
(lp2642
s(S'GFI1'
p2643
S'HOXA9'
p2644
S'increases'
p2645
tp2646
(lp2647
s(S'NR1H4'
p2648
S'FOXD3'
p2649
S'increases'
p2650
tp2651
(lp2652
s(S'STAT6'
p2653
S'FOXA1'
p2654
S'increases'
p2655
tp2656
(lp2657
s(S'INSULIN RECEPTOR/INSULI/IRS1/GRB2/SHC'
p2658
S'SOS1'
p2659
S'binds'
p2660
tp2661
(lp2662
s(S'Tetrachlorodibenzodioxin'
p2663
S'KRAS MRNA'
p2664
S'increases'
p2665
tp2666
(lp2667
s(S'TCF3'
p2668
S'MYC'
p2669
S'increases'
p2670
tp2671
(lp2672
s(S'BACH1'
p2673
S'EN1'
p2674
S'increases'
p2675
tp2676
(lp2677
s(S'RFX1'
p2678
S'CYP26A1'
p2679
S'increases'
p2680
tp2681
(lp2682
s(S'ZEB1'
p2683
S'FOXD3'
p2684
S'increases'
p2685
tp2686
(lp2687
s(S'IRF7'
p2688
S'EN1'
p2689
S'increases'
p2690
tp2691
(lp2692
s(S'GAB2/GRB2/SOS1'
p2693
S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/SHC'
p2694
S'binds'
p2695
tp2696
(lp2697
s(S'GATA3'
p2698
S'FOXA1'
p2699
S'increases'
p2700
tp2701
(lp2702
S'This validation was carried out for MRs whose regulons were enriched in the cancer and normal breast tissue, but not in T-ALL: ESR1, FOXA1, GATA3 and SPDEF.'
p2703
aS'Bioinformatic analysis using position weight matrices (PWM, consensus binding motifs) from Transfac showed a strong enrichment of binding motifs for ESR1, FOXA1 and GATA3 in each of their identified regulons ('
p2704
aS'Having defined the regulons, we investigated how risk SNPs are distributed among them and carried out a cis-eQTL analysis between the risk SNP list (AVS) and the genes in the regulons for each of the MRs. Our analysis showed a statistically significant enrichment for genes in the ESR1, GATA3 and FOXA1 regulons with breast cancer risk SNPs but not prostate, colon or BMD risk SNPs ('
p2705
aS'In conclusion, we demonstrate that at least three of the identified MRs, ESR1, GATA3 and FOXA1 are linked to risk gene expression.'
p2706
as(S'TFAP4'
p2707
S'CYP26A1'
p2708
S'increases'
p2709
tp2710
(lp2711
s(S'FOXF2'
p2712
S'MECOM'
p2713
S'increases'
p2714
tp2715
(lp2716
s(S'NF1'
p2717
S'POU2F1'
p2718
S'increases'
p2719
tp2720
(lp2721
s(S'IRF1'
p2722
S'FOXA1'
p2723
S'increases'
p2724
tp2725
(lp2726
s(S'Rho Family GTPase-active'
p2727
S'PIP5K1A'
p2728
S'increases_activity'
p2729
tp2730
(lp2731
s(S'POU6F1'
p2732
S'EN1'
p2733
S'increases'
p2734
tp2735
(lp2736
s(S'TCF4'
p2737
S'LEF1'
p2738
S'increases'
p2739
tp2740
(lp2741
s(S'MAZ'
p2742
S'FOXO3'
p2743
S'increases'
p2744
tp2745
(lp2746
s(S'POU3F2'
p2747
S'MECOM'
p2748
S'increases'
p2749
tp2750
(lp2751
s(S'GTF3A'
p2752
S'CYP26A1'
p2753
S'increases'
p2754
tp2755
(lp2756
s(S'PI-3-4-5-P3'
p2757
S'AKT2'
p2758
S'adds_modification'
p2759
tp2760
(lp2761
s(S'VSX1'
p2762
S'POU2F1'
p2763
S'increases'
p2764
tp2765
(lp2766
s(S'PHOSPHORYLATED TTP:MRNA COMPLEX'
p2767
S'YWHAB'
p2768
S'binds'
p2769
tp2770
(lp2771
s(S'MEIS1'
p2772
S'MYC'
p2773
S'increases'
p2774
tp2775
(lp2776
s(S'Complex (PDGF receptor A/PDGF receptor B)'
p2777
S'RASGAP'
p2778
S'adds_modification'
p2779
tp2780
(lp2781
s(S'RORA'
p2782
S'CYP26A1'
p2783
S'increases'
p2784
tp2785
(lp2786
s(S'ATF4'
p2787
S'CDC5L'
p2788
S'increases'
p2789
tp2790
(lp2791
s(S'SHC/RasGAP'
p2792
S'RAS FAMILY/GTP'
p2793
S'increases_activity'
p2794
tp2795
(lp2796
s(S'NKX2-1'
p2797
S'MYC'
p2798
S'increases'
p2799
tp2800
(lp2801
s(S'NF1'
p2802
S'SRF'
p2803
S'increases'
p2804
tp2805
(lp2806
s(S'STAT4'
p2807
S'NRAS'
p2808
S'increases'
p2809
tp2810
(lp2811
s(S'POU6F1'
p2812
S'MEIS1'
p2813
S'increases'
p2814
tp2815
(lp2816
s(S'P-KIT COMPLEX'
p2817
S'GRB2:SOS1'
p2818
S'binds'
p2819
tp2820
(lp2821
s(S'MYCN'
p2822
S'MAX'
p2823
S'increases'
p2824
tp2825
(lp2826
s(S'STAT5A'
p2827
S'CYP26A1'
p2828
S'increases'
p2829
tp2830
(lp2831
s(S'GATA3'
p2832
S'EN1'
p2833
S'increases'
p2834
tp2835
(lp2836
s(S'E4F1'
p2837
S'FOXD3'
p2838
S'increases'
p2839
tp2840
(lp2841
s(S'MYB'
p2842
S'ONECUT1'
p2843
S'increases'
p2844
tp2845
(lp2846
s(S'Cadmium Chloride'
p2847
S'NRAS PROTEIN'
p2848
S'increases'
p2849
tp2850
(lp2851
s(S'Deoxycholic Acid'
p2852
S'HRAS PROTEIN'
p2853
S'increases_activity'
p2854
tp2855
(lp2856
s(S'HLF'
p2857
S'CYP26A1'
p2858
S'increases'
p2859
tp2860
(lp2861
s(S'GMCSF/GMR ALPHA/CSF2RB/JAK2 (DIMER)'
p2862
S'YWHAZ'
p2863
S'binds'
p2864
tp2865
(lp2866
s(S'HNF1A'
p2867
S'FOXF2'
p2868
S'increases'
p2869
tp2870
(lp2871
s(S'FOXF2'
p2872
S'GATA6'
p2873
S'increases'
p2874
tp2875
(lp2876
s(S'Arsenic'
p2877
S'GSS PROTEIN'
p2878
S'increases'
p2879
tp2880
(lp2881
s(S'COMPLEX (SOS/GRB2)'
p2882
S'FGFR1-4'
p2883
S'binds'
p2884
tp2885
(lp2886
s(S'MYOD1'
p2887
S'NRAS'
p2888
S'increases'
p2889
tp2890
(lp2891
s(S'MECOM'
p2892
S'CYP26A1'
p2893
S'increases'
p2894
tp2895
(lp2896
s(S'PBX1'
p2897
S'CYP26A1'
p2898
S'increases'
p2899
tp2900
(lp2901
s(S'MAZ'
p2902
S'MEIS1'
p2903
S'increases'
p2904
tp2905
(lp2906
s(S'PAX4'
p2907
S'ELK1'
p2908
S'increases'
p2909
tp2910
(lp2911
s(S'ESRRA'
p2912
S'MECOM'
p2913
S'increases'
p2914
tp2915
(lp2916
s(S'CEBPD'
p2917
S'TLX2'
p2918
S'increases'
p2919
tp2920
(lp2921
s(S'CRX'
p2922
S'FOXA1'
p2923
S'increases'
p2924
tp2925
(lp2926
s(S'GABPB1'
p2927
S'NRAS'
p2928
S'increases'
p2929
tp2930
(lp2931
s(S'CRX'
p2932
S'MEIS1'
p2933
S'increases'
p2934
tp2935
(lp2936
s(S'pirinixic acid/PPARA protein'
p2937
S'KRAS MRNA'
p2938
S'increases'
p2939
tp2940
(lp2941
s(S'BACH2'
p2942
S'FOXA1'
p2943
S'increases'
p2944
tp2945
(lp2946
s(S'JUN'
p2947
S'MECOM'
p2948
S'increases'
p2949
tp2950
(lp2951
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p2952
S'KRAS MRNA'
p2953
S'decreases'
p2954
tp2955
(lp2956
s(S'SRY'
p2957
S'FOXO4'
p2958
S'increases'
p2959
tp2960
(lp2961
s(S'PI3K'
p2962
S'AKT1'
p2963
S'adds_modification'
p2964
tp2965
(lp2966
S'To test whether phosphorylation of cortactin could also be regulated by AKT1 in other cells with alterations in the PI3K signaling pathway, we used another isogenic cell line pair derived from the colorectal cancer cell line DLD1'
p2967
aS'In summary, mutant PI3K-induced signaling events uncovered by our phosphoproteomic approaches along with the newly identified AKT1 substrates should be invaluable for research as well as clinical studies involving development of novel targeted therapies.'
p2968
aS'AKT1 mediated phosphorylation on cortactin is important for migration/invasion induced by activation of PI3K.'
p2969
as(S'GATA3'
p2970
S'CYP26A1'
p2971
S'increases'
p2972
tp2973
(lp2974
s(S'RAS:GTP'
p2975
S'P-EPHBS:EFNBS:RASA1'
p2976
S'binds'
p2977
tp2978
(lp2979
s(S'STAT5A'
p2980
S'MECOM'
p2981
S'increases'
p2982
tp2983
(lp2984
s(S'RAS family/GTP'
p2985
S'RAF1'
p2986
S'increases_activity'
p2987
tp2988
(lp2989
s(S'RHOA/GTP'
p2990
S'PLD1-2'
p2991
S'increases_activity'
p2992
tp2993
(lp2994
s(S'FOXJ2'
p2995
S'CYP26A1'
p2996
S'increases'
p2997
tp2998
(lp2999
s(S'LEF1'
p3000
S'MECOM'
p3001
S'increases'
p3002
tp3003
(lp3004
s(S'GABPB2'
p3005
S'CDC5L'
p3006
S'increases'
p3007
tp3008
(lp3009
s(S'ESRRA'
p3010
S'CYP26A1'
p3011
S'increases'
p3012
tp3013
(lp3014
s(S'PI-3-4-5-P3'
p3015
S'WAVE2/NAP1/SRA1/ABI1/HSPC300'
p3016
S'translocates'
p3017
tp3018
(lp3019
s(S'CUX1'
p3020
S'MECOM'
p3021
S'increases'
p3022
tp3023
(lp3024
s(S'MAX'
p3025
S'CYP26A1'
p3026
S'increases'
p3027
tp3028
(lp3029
s(S'RXRB'
p3030
S'FOXD3'
p3031
S'increases'
p3032
tp3033
(lp3034
s(S'IRF1'
p3035
S'NRAS'
p3036
S'increases'
p3037
tp3038
(lp3039
s(S'MECOM'
p3040
S'MAX'
p3041
S'increases'
p3042
tp3043
(lp3044
s(S'PAX6'
p3045
S'CYP26A1'
p3046
S'increases'
p3047
tp3048
(lp3049
s(S'GRB2/SOS1'
p3050
S'EGFR/EGFR/EGF/EGF/P46 SHC'
p3051
S'binds'
p3052
tp3053
(lp3054
s(S'POU6F1'
p3055
S'POU2F1'
p3056
S'increases'
p3057
tp3058
(lp3059
s(S'RUNX1'
p3060
S'MYOD1'
p3061
S'increases'
p3062
tp3063
(lp3064
s(S'COMPLEX (GRB2/SOS)'
p3065
S'EGFR'
p3066
S'binds'
p3067
tp3068
(lp3069
s(S'MAZ'
p3070
S'MECOM'
p3071
S'increases'
p3072
tp3073
(lp3074
s(S'REPIN1'
p3075
S'EN1'
p3076
S'increases'
p3077
tp3078
(lp3079
s(S'RAS family/GTP'
p3080
S'RAF1'
p3081
S'adds_modification'
p3082
tp3083
(lp3084
s(S'E4F1'
p3085
S'CYP26A1'
p3086
S'increases'
p3087
tp3088
(lp3089
s(S'Rac'
p3090
S'MEKK1-5'
p3091
S'adds_modification'
p3092
tp3093
(lp3094
s(S'HAND1'
p3095
S'CYP26A1'
p3096
S'increases'
p3097
tp3098
(lp3099
s(S'Quercetin'
p3100
S'NRAS PROTEIN'
p3101
S'decreases'
p3102
tp3103
(lp3104
s(S'HRAS:GTP'
p3105
S'CRAF'
p3106
S'binds'
p3107
tp3108
(lp3109
s(S'REPIN1'
p3110
S'FOXA1'
p3111
S'increases'
p3112
tp3113
(lp3114
s(S'hsa-miR-155-5p'
p3115
S'KRAS'
p3116
S'decreases'
p3117
tp3118
(lp3119
s(S'PAX4'
p3120
S'EN1'
p3121
S'increases'
p3122
tp3123
(lp3124
s(S'FOXN1'
p3125
S'JUN'
p3126
S'increases'
p3127
tp3128
(lp3129
s(S'TFCP2'
p3130
S'GATA1'
p3131
S'increases'
p3132
tp3133
(lp3134
s(S'SHC'
p3135
S'GRAP2'
p3136
S'binds'
p3137
tp3138
(lp3139
s(S'CEBPG'
p3140
S'NRAS'
p3141
S'increases'
p3142
tp3143
(lp3144
s(S'FOXN1'
p3145
S'FOXO4'
p3146
S'increases'
p3147
tp3148
(lp3149
s(S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/IRS1-2'
p3150
S'PI3K'
p3151
S'binds'
p3152
tp3153
(lp3154
s(S'POU1F1'
p3155
S'EN1'
p3156
S'increases'
p3157
tp3158
(lp3159
s(S'FOXJ1'
p3160
S'POU2F1'
p3161
S'increases'
p3162
tp3163
(lp3164
s(S'YY1'
p3165
S'POU2F1'
p3166
S'increases'
p3167
tp3168
(lp3169
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p3170
S'NRAS MRNA'
p3171
S'increases'
p3172
tp3173
(lp3174
s(S'EGF/EGFR'
p3175
S'HRAS/GDP'
p3176
S'increases_activity'
p3177
tp3178
(lp3179
s(S'TFAP4'
p3180
S'GABPB2'
p3181
S'increases'
p3182
tp3183
(lp3184
s(S'TFAP2A'
p3185
S'POU3F2'
p3186
S'increases'
p3187
tp3188
(lp3189
s(S'TCF12'
p3190
S'CBFA2T3'
p3191
S'increases'
p3192
tp3193
(lp3194
s(S'STAT3'
p3195
S'IRF1'
p3196
S'increases'
p3197
tp3198
(lp3199
s(S'MYOD1'
p3200
S'GATA1'
p3201
S'increases'
p3202
tp3203
(lp3204
s(S'REPIN1'
p3205
S'HRAS'
p3206
S'increases'
p3207
tp3208
(lp3209
s(S'PAX4'
p3210
S'MAX'
p3211
S'increases'
p3212
tp3213
(lp3214
s(S'PAX2'
p3215
S'FOXA1'
p3216
S'increases'
p3217
tp3218
(lp3219
s(S'Lipopolysaccharides'
p3220
S'HRAS PROTEIN'
p3221
S'increases_activity'
p3222
tp3223
(lp3224
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p3225
S'KRAS MRNA'
p3226
S'increases'
p3227
tp3228
(lp3229
s(S'REPIN1'
p3230
S'GATA1'
p3231
S'increases'
p3232
tp3233
(lp3234
s(S'Formaldehyde'
p3235
S'HRAS MRNA'
p3236
S'increases'
p3237
tp3238
(lp3239
s(S'ESRRA'
p3240
S'STAT5A'
p3241
S'increases'
p3242
tp3243
(lp3244
s(S'farnesylthiosalicylic acid'
p3245
S'HRAS PROTEIN'
p3246
S'decreases'
p3247
tp3248
(lp3249
s(S'JUN'
p3250
S'RUNX1'
p3251
S'increases'
p3252
tp3253
(lp3254
s(S'FOXD3'
p3255
S'RUNX1'
p3256
S'increases'
p3257
tp3258
(lp3259
s(S'SOX9'
p3260
S'CYP26A1'
p3261
S'increases'
p3262
tp3263
(lp3264
s(S'hexabromocyclododecane'
p3265
S'HRAS MRNA'
p3266
S'increases'
p3267
tp3268
(lp3269
s(S'RUNX2'
p3270
S'KRAS'
p3271
S'increases'
p3272
tp3273
(lp3274
s(S'PGR'
p3275
S'CYP26A1'
p3276
S'increases'
p3277
tp3278
(lp3279
s(S'CYP26A1'
p3280
S'MAZ'
p3281
S'increases'
p3282
tp3283
(lp3284
s(S'RAC1/GTP'
p3285
S'AKT1'
p3286
S'adds_modification'
p3287
tp3288
(lp3289
s(S'FOXO3'
p3290
S'CYP26A1'
p3291
S'increases'
p3292
tp3293
(lp3294
s(S'MAX'
p3295
S'SRF'
p3296
S'increases'
p3297
tp3298
(lp3299
S'Part of this work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), Stanford Synchrotron Radiation Laboratory (SSRL), European Synchrotron Research Facility (ESRF), and MAX-lab (Lund University).'
p3300
aS'acknowledges the experimental assistance of Dorthe Boelskifte and the ESRF and MAXLAB staff for assistance with data collection.'
p3301
aS'The authors would like to acknowledge the beamline scientists at ESRF, France, SLS, Switzerland, BESSY, Germany and MAX-lab, Sweden.'
p3302
aS'The position-specific weight matrices (PWM) for CTCF, MAX, SIX5, USF1, BCL11A, EGR1, NANOG, RAD21, RFX5, SRF, USF2, GABP, NRSF, YY1, CJUN, JUND, OCT4 and TCF12 were downloaded from JASPAR ('
p3303
as(S'RUNX2'
p3304
S'NRAS'
p3305
S'increases'
p3306
tp3307
(lp3308
s(S'HSF2'
p3309
S'CYP26A1'
p3310
S'increases'
p3311
tp3312
(lp3313
s(S'IL2/IL2R ALPHA/BETA/GAMMA/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2'
p3314
S'PI3K'
p3315
S'binds'
p3316
tp3317
(lp3318
s(S'SPI1'
p3319
S'STAT5A'
p3320
S'increases'
p3321
tp3322
(lp3323
s(S'ZHX2'
p3324
S'MYC'
p3325
S'increases'
p3326
tp3327
(lp3328
s(S'RAF1-BRAF'
p3329
S'MEK1-2'
p3330
S'increases_activity'
p3331
tp3332
(lp3333
s(S'SHC'
p3334
S'GRB2'
p3335
S'binds'
p3336
tp3337
(lp3338
s(S'RB1'
p3339
S'GATA1'
p3340
S'increases'
p3341
tp3342
(lp3343
s(S'TCF3'
p3344
S'FOXJ2'
p3345
S'increases'
p3346
tp3347
(lp3348
s(S'FOXJ2'
p3349
S'NRAS'
p3350
S'increases'
p3351
tp3352
(lp3353
s(S'REPIN1'
p3354
S'LEF1'
p3355
S'increases'
p3356
tp3357
(lp3358
s(S'Aflatoxin B1'
p3359
S'HRAS MRNA'
p3360
S'increases'
p3361
tp3362
(lp3363
s(S'PAX4'
p3364
S'MEIS1'
p3365
S'increases'
p3366
tp3367
(lp3368
s(S'FOXF2'
p3369
S'FOXD3'
p3370
S'increases'
p3371
tp3372
(lp3373
s(S'CBFA2T3'
p3374
S'RUNX1'
p3375
S'increases'
p3376
tp3377
(lp3378
s(S'FOXC1'
p3379
S'HOXA9'
p3380
S'increases'
p3381
tp3382
(lp3383
s(S'DBP'
p3384
S'CYP26A1'
p3385
S'increases'
p3386
tp3387
(lp3388
s(S'TGIF'
p3389
S'EN1'
p3390
S'increases'
p3391
tp3392
(lp3393
s(S'PI-3-4-5-P3'
p3394
S'P62DOK'
p3395
S'adds_modification'
p3396
tp3397
(lp3398
s(S'JUN'
p3399
S'TLX2'
p3400
S'increases'
p3401
tp3402
(lp3403
s(S'Benzo(a)pyrene'
p3404
S'HRAS MRNA'
p3405
S'increases'
p3406
tp3407
(lp3408
s(S'STAT4'
p3409
S'CYP26A1'
p3410
S'increases'
p3411
tp3412
(lp3413
s(S'EGFR/EGFR/EGF/EGF'
p3414
S'SRC'
p3415
S'adds_modification'
p3416
tp3417
(lp3418
s(S'FOXQ1'
p3419
S'FOXD3'
p3420
S'increases'
p3421
tp3422
(lp3423
s(S'FOXJ1'
p3424
S'NRAS'
p3425
S'increases'
p3426
tp3427
(lp3428
s(S'TCF3'
p3429
S'POU2F1'
p3430
S'increases'
p3431
tp3432
(lp3433
s(S'MYB'
p3434
S'CYP26A1'
p3435
S'increases'
p3436
tp3437
(lp3438
s(S'GATA4'
p3439
S'CYP26A1'
p3440
S'increases'
p3441
tp3442
(lp3443
s(S'ELK1'
p3444
S'STAT4'
p3445
S'increases'
p3446
tp3447
(lp3448
s(S'CYP26A1'
p3449
S'LEF1'
p3450
S'increases'
p3451
tp3452
(lp3453
s(S"Guanosine-5'-Diphosphate"
p3454
S'HRAS'
p3455
S'increases_activity'
p3456
tp3457
(lp3458
s(S'ETV4'
p3459
S'CYP26A1'
p3460
S'increases'
p3461
tp3462
(lp3463
s(S'EPHRIN B/EPHB2'
p3464
S'RASGAP'
p3465
S'binds'
p3466
tp3467
(lp3468
s(S'ESR1'
p3469
S'FOXF2'
p3470
S'increases'
p3471
tp3472
(lp3473
s(S'CDC5L'
p3474
S'FOXA1'
p3475
S'increases'
p3476
tp3477
(lp3478
s(S'MAZ'
p3479
S'HOXA9'
p3480
S'increases'
p3481
tp3482
(lp3483
s(S'HIF1A'
p3484
S'MAX'
p3485
S'increases'
p3486
tp3487
(lp3488
s(S'FOXN1'
p3489
S'HOXA9'
p3490
S'increases'
p3491
tp3492
(lp3493
s(S'LEF1'
p3494
S'BACH1'
p3495
S'increases'
p3496
tp3497
(lp3498
s(S'PDX1'
p3499
S'FOXO3'
p3500
S'increases'
p3501
tp3502
(lp3503
s(S'CBFA2T3'
p3504
S'CYP26A1'
p3505
S'increases'
p3506
tp3507
(lp3508
s(S'Rabex5'
p3509
S'HRAS/GTP'
p3510
S'adds_modification'
p3511
tp3512
(lp3513
s(S'CBFA2T3'
p3514
S'RUNX2'
p3515
S'increases'
p3516
tp3517
(lp3518
s(S'PI-3-4-5-P3'
p3519
S'ARAP3'
p3520
S'translocates'
p3521
tp3522
(lp3523
s(S'CART1'
p3524
S'CYP26A1'
p3525
S'increases'
p3526
tp3527
(lp3528
s(S'Arsenic'
p3529
S'NRAS MRNA'
p3530
S'increases'
p3531
tp3532
(lp3533
s(S'NRF1'
p3534
S'CDC5L'
p3535
S'increases'
p3536
tp3537
(lp3538
s(S'Quercetin'
p3539
S'HRAS PROTEIN'
p3540
S'decreases'
p3541
tp3542
(lp3543
s(S"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE"
p3544
S'HRAS'
p3545
S'increases_activity'
p3546
tp3547
(lp3548
s(S'TFDP1'
p3549
S'FOXD3'
p3550
S'increases'
p3551
tp3552
(lp3553
s(S'AR'
p3554
S'TLX2'
p3555
S'increases'
p3556
tp3557
(lp3558
s(S'hsa-miR-181c-5p'
p3559
S'KRAS'
p3560
S'decreases'
p3561
tp3562
(lp3563
s(S'SMAD3'
p3564
S'CBFA2T3'
p3565
S'increases'
p3566
tp3567
(lp3568
s(S'HOXA9'
p3569
S'NRAS'
p3570
S'increases'
p3571
tp3572
(lp3573
s(S'PITX2'
p3574
S'CYP26A1'
p3575
S'increases'
p3576
tp3577
(lp3578
s(S'ATF3'
p3579
S'CYP26A1'
p3580
S'increases'
p3581
tp3582
(lp3583
s(S'E2F1'
p3584
S'MAZ'
p3585
S'increases'
p3586
tp3587
(lp3588
s(S'Ethyl Methanesulfonate'
p3589
S'HRAS MRNA'
p3590
S'increases'
p3591
tp3592
(lp3593
s(S'LMO2'
p3594
S'FOXA1'
p3595
S'increases'
p3596
tp3597
(lp3598
s(S'FOXC1'
p3599
S'POU2F1'
p3600
S'increases'
p3601
tp3602
(lp3603
s(S'DDIT3'
p3604
S'CYP26A1'
p3605
S'increases'
p3606
tp3607
(lp3608
s(S'PAX8'
p3609
S'CYP26A1'
p3610
S'increases'
p3611
tp3612
(lp3613
s(S'LHX3'
p3614
S'EN1'
p3615
S'increases'
p3616
tp3617
(lp3618
s(S'KAT2B'
p3619
S'CYP26A1'
p3620
S'increases'
p3621
tp3622
(lp3623
s(S'P100'
p3624
S'MYB'
p3625
S'binds'
p3626
tp3627
(lp3628
s(S'SOX9'
p3629
S'FOXA1'
p3630
S'increases'
p3631
tp3632
(lp3633
s(S'HIF1A'
p3634
S'EN1'
p3635
S'increases'
p3636
tp3637
(lp3638
s(S'REPIN1'
p3639
S'RUNX1'
p3640
S'increases'
p3641
tp3642
(lp3643
s(S'MYOD1'
p3644
S'BACH1'
p3645
S'increases'
p3646
tp3647
(lp3648
s(S'EBF2'
p3649
S'REPIN1'
p3650
S'increases'
p3651
tp3652
(lp3653
s(S'bisphenol A'
p3654
S'HRAS MRNA'
p3655
S'increases'
p3656
tp3657
(lp3658
s(S'E2F1'
p3659
S'EN1'
p3660
S'increases'
p3661
tp3662
(lp3663
s(S'MYC/Max/MIZ-1'
p3664
S'GALECTIN-1'
p3665
S'decreases'
p3666
tp3667
(lp3668
s(S'PI-3-4-5-P3'
p3669
S'WAVE2/NAP1/SRA1/ABI1/HSPC300'
p3670
S'adds_modification'
p3671
tp3672
(lp3673
s(S'FOXF2'
p3674
S'FOXO3'
p3675
S'increases'
p3676
tp3677
(lp3678
s(S'REPIN1'
p3679
S'STAT5A'
p3680
S'increases'
p3681
tp3682
(lp3683
s(S'RUNX1'
p3684
S'NRAS'
p3685
S'increases'
p3686
tp3687
(lp3688
s(S'benzo(a)pyrene 7,8-dihydrodiol'
p3689
S'HRAS MRNA'
p3690
S'increases'
p3691
tp3692
(lp3693
s(S'RAC1/GTP'
p3694
S'PAK1 (DIMER)'
p3695
S'adds_modification'
p3696
tp3697
(lp3698
s(S'PAX4'
p3699
S'POU2F1'
p3700
S'increases'
p3701
tp3702
(lp3703
s(S'MYOD1'
p3704
S'CBFA2T3'
p3705
S'increases'
p3706
tp3707
(lp3708
s(S'STAT5A'
p3709
S'RUNX2'
p3710
S'increases'
p3711
tp3712
(lp3713
s(S'EBF2'
p3714
S'FOXJ2'
p3715
S'increases'
p3716
tp3717
(lp3718
s(S'Estradiol'
p3719
S'KRAS MRNA'
p3720
S'increases'
p3721
tp3722
(lp3723
s(S'RXRB'
p3724
S'CYP26A1'
p3725
S'increases'
p3726
tp3727
(lp3728
s(S'bisphenol A'
p3729
S'KRAS MRNA'
p3730
S'decreases'
p3731
tp3732
(lp3733
s(S'COMPLEX (GRB2/SOS)'
p3734
S'FGFR1-4'
p3735
S'binds'
p3736
tp3737
(lp3738
s(S'POU2F1'
p3739
S'RUNX1'
p3740
S'increases'
p3741
tp3742
(lp3743
s(S'TCF3'
p3744
S'TLX2'
p3745
S'increases'
p3746
tp3747
(lp3748
s(S'SPZ1'
p3749
S'POU2F1'
p3750
S'increases'
p3751
tp3752
(lp3753
s(S'TFAP4'
p3754
S'FOXO4'
p3755
S'increases'
p3756
tp3757
(lp3758
s(S'OR5I1'
p3759
S'MECOM'
p3760
S'increases'
p3761
tp3762
(lp3763
s(S'Rho Family GTPase-active'
p3764
S'JNK1'
p3765
S'adds_modification'
p3766
tp3767
(lp3768
s(S'TFDP1'
p3769
S'POU2F1'
p3770
S'increases'
p3771
tp3772
(lp3773
s(S'AHR'
p3774
S'MAX'
p3775
S'increases'
p3776
tp3777
(lp3778
S'Top-ranked FFLs that are common across the six cancer data sets consist of TFs USF1, ARNT, MYC, MAX, AHR, CREB1 and miRNAs mir-15a, miR-16, miR-17, miR-20a and miR-195 ('
p3779
as(S'BACH1'
p3780
S'CYP26A1'
p3781
S'increases'
p3782
tp3783
(lp3784
s(S'ZBTB14'
p3785
S'MAZ'
p3786
S'increases'
p3787
tp3788
(lp3789
s(S'TCF3'
p3790
S'FOXO4'
p3791
S'increases'
p3792
tp3793
(lp3794
s(S'MASTERMIND'
p3795
S'NICS'
p3796
S'binds'
p3797
tp3798
(lp3799
s(S'BPTF'
p3800
S'FOXO4'
p3801
S'increases'
p3802
tp3803
(lp3804
s(S'MYOD1'
p3805
S'RUNX1'
p3806
S'increases'
p3807
tp3808
(lp3809
s(S'JUN'
p3810
S'CYP26A1'
p3811
S'increases'
p3812
tp3813
(lp3814
s(S'BPTF'
p3815
S'CYP26A1'
p3816
S'increases'
p3817
tp3818
(lp3819
s(S'POU3F1'
p3820
S'CYP26A1'
p3821
S'increases'
p3822
tp3823
(lp3824
s(S'NRF1'
p3825
S'CYP26A1'
p3826
S'increases'
p3827
tp3828
(lp3829
s(S'TFAP2C'
p3830
S'POU3F2'
p3831
S'increases'
p3832
tp3833
(lp3834
s(S'NFAT1-C-4-INACTIVE2'
p3835
S'YWHAQ'
p3836
S'binds'
p3837
tp3838
(lp3839
s(S'STAT6'
p3840
S'ONECUT1'
p3841
S'increases'
p3842
tp3843
(lp3844
s(S'RUNX1'
p3845
S'RUNX2'
p3846
S'increases'
p3847
tp3848
(lp3849
s(S'ZIC3'
p3850
S'MYCN'
p3851
S'increases'
p3852
tp3853
(lp3854
s(S'CYP26A1'
p3855
S'MAX'
p3856
S'increases'
p3857
tp3858
(lp3859
s(S'ETS2'
p3860
S'FOXO4'
p3861
S'increases'
p3862
tp3863
(lp3864
s(S'GATA6'
p3865
S'FOXA1'
p3866
S'increases'
p3867
tp3868
(lp3869
s(S'Doxorubicin'
p3870
S'HRAS MRNA'
p3871
S'increases'
p3872
tp3873
(lp3874
s(S'PPARA'
p3875
S'HOXA9'
p3876
S'increases'
p3877
tp3878
(lp3879
s(S'REPIN1'
p3880
S'GABPB2'
p3881
S'increases'
p3882
tp3883
(lp3884
s(S'FOXN1'
p3885
S'FOXA1'
p3886
S'increases'
p3887
tp3888
(lp3889
s(S'Dronabinol'
p3890
S'KRAS MRNA'
p3891
S'increases'
p3892
tp3893
(lp3894
s(S'FOXO1'
p3895
S'RUNX1'
p3896
S'increases'
p3897
tp3898
(lp3899
s(S'SMAD4'
p3900
S'HOXA9'
p3901
S'increases'
p3902
tp3903
(lp3904
s(S'PAX4'
p3905
S'JUN'
p3906
S'increases'
p3907
tp3908
(lp3909
s(S'Raf-1'
p3910
S'MEK'
p3911
S'adds_modification'
p3912
tp3913
(lp3914
g662
ag663
as(S'PIM1'
p3915
S'MYC/MAX'
p3916
S'binds'
p3917
tp3918
(lp3919
s(S'YY1'
p3920
S'MECOM'
p3921
S'increases'
p3922
tp3923
(lp3924
s(S'NRF1'
p3925
S'MAZ'
p3926
S'increases'
p3927
tp3928
(lp3929
s(S'GATA1'
p3930
S'MECOM'
p3931
S'increases'
p3932
tp3933
(lp3934
s(S'PDGF/PDGFRA'
p3935
S'SHC/GRB2/SOS1'
p3936
S'increases_activity'
p3937
tp3938
(lp3939
s(S'GRB2/SOS1'
p3940
S'FAK'
p3941
S'binds'
p3942
tp3943
(lp3944
s(S'HNF4A'
p3945
S'HOXA9'
p3946
S'increases'
p3947
tp3948
(lp3949
s(S'FOXA2'
p3950
S'CYP26A1'
p3951
S'increases'
p3952
tp3953
(lp3954
s(S'FOXI1'
p3955
S'CYP26A1'
p3956
S'increases'
p3957
tp3958
(lp3959
s(S'GRB2 BOUND TO TIE2'
p3960
S'SOS1'
p3961
S'binds'
p3962
tp3963
(lp3964
s(S'PHOSPHORYLATED BRF1 (SER54, SER92, SER203):MRNA COMPLEX'
p3965
S'YWHAB'
p3966
S'binds'
p3967
tp3968
(lp3969
s(S'COMPLEX (GRB2/SOS)'
p3970
S'GAB'
p3971
S'binds'
p3972
tp3973
(lp3974
s(S'NFE2'
p3975
S'TLX2'
p3976
S'increases'
p3977
tp3978
(lp3979
s(S'MAX'
p3980
S'FOXF2'
p3981
S'increases'
p3982
tp3983
(lp3984
s(S'GRB2:SOS1'
p3985
S'ACTIVATED FGFR:P-FRS2'
p3986
S'binds'
p3987
tp3988
(lp3989
s(S'FOXO4'
p3990
S'MECOM'
p3991
S'increases'
p3992
tp3993
(lp3994
s(S'TCF3'
p3995
S'LEF1'
p3996
S'increases'
p3997
tp3998
(lp3999
S'In support of this, it has been shown that TCF3 and LEF1 have contrasting effects on formation of the embryonic body axis in '
p4000
aS'By comparing the transactivation potential of LEF1, TCF1B, TCF1E and TCF3, it was found earlier that only TCF1E was able to activate the P1 promoter of the human '
p4001
as(S'ZIC1'
p4002
S'LEF1'
p4003
S'increases'
p4004
tp4005
(lp4006
s(S'NFIL3'
p4007
S'CYP26A1'
p4008
S'increases'
p4009
tp4010
(lp4011
s(S'RAF1'
p4012
S'MEK1'
p4013
S'increases_activity'
p4014
tp4015
(lp4016
s(S'AR'
p4017
S'FOXA1'
p4018
S'increases'
p4019
tp4020
(lp4021
S'Cistromes and epigenomes assessed in these cell lines for factors and modifications including FOXA1, ESR2, AR and H3K4me1 did not show enrichment for the BCa AVS, demonstrating that the enrichment of the BCa AVS is cell-type-specific ('
p4022
aS'(a) Proportion of ChIP-seq enriched regions discovered as DNaseI hypersensitive (DHS) sites for CTCF (left), androgen receptor (AR, center) and FOXA1 (right) in LNCaP cells.'
p4023
aS'The pioneering factor FOXA1 opens chromatin to facilitate androgen receptor (AR) binding to prostate-specific genes.'
p4024
aS'How FOXA1 controls the AR cistrome, however, is incompletely understood.'
p4025
aS'FOXA1 is not required for AR-chromatin interaction, but instrumental in recruiting AR to low-affinity half-AREs by opening local chromatin around adjacent FKHD sites.'
p4026
aS'Too much FOXA1 creates excessive open chromatin regions, which serve as reservoirs that retain AR via abundant half-AREs, thereby reducing its availability for specific sites.'
p4027
aS'FOXA1 down-regulation, by contrast, relinquishes AR to permissively bind AREs across the genome, resulting in substantial AR binding events and AR-target gene expression even in the absence of androgen.'
p4028
aS'Taken together, our data illustrate the mechanistic details by which cooperativity and equilibrium with FOXA1 define AR cistrome and reveal a previously unknown function of FOXA1 in inhibiting AR signaling and castration-resistant prostate cancer growth.'
p4029
aS'Genome-wide location analyses comparing FOXA1-bound genomic regions in prostate and breast cancer cells have revealed cell type-specific recruitment, which subsequently dictates distinct AR and ER chromatin-binding patterns in prostate and breast cells, respectively'
p4030
aS'To determine how FOXA1 defines AR binding profile, we first conducted FOXA1 knockdown (KD) in LNCaP PCa cells and then performed AR and FOXA1 ChIP-Seq in both control and knockdown cells ('
p4031
aS'Our data thus strongly suggest a shifted and gained AR program in PCa cells following the silencing of FOXA1.'
p4032
aS'Motif analysis revealed that strong ARBS (shared and shFOXA1-only) were characterized by high (~30%) incidences of full-ARE motif, while only 7% of shCtrl-only ARBS contained an ARE ('
p4033
aS'To test the importance of direct AR-chromatin interaction, we generated AR mutants C562S and G568W that are deficient in DNA binding but remained capable of interacting with the FOXA1 protein ('
p4034
aS'To engineer an independent model to further examine how FOXA1 regulates AR binding profile, we overexpressed AR in the FOXA1-negative DU145 cells to generate stable cell lines (DU145+AR) ('
p4035
aS'We engineered DU145+AR cells to express very high amount of FOXA1 ('
p4036
aS'As FOXA1 has been previously shown to open up compact chromatin to facilitate the access of other transcription factors including AR'
p4037
aS'Next we investigated how excessive FOXA1 results in immense loss of total AR binding events as illustrated in '
p4038
aS'We generated an AR mutant (Q640X) that only expresses the AR protein up to position 640 which has been previously shown unable to interact with the FOXA1 protein'
p4039
aS'Concordantly, we found that in the absence of FOXA1, the intensity of ARE-only ARBS was the same as those bound to ARE+FKHD sites, both of which were significantly stronger than the FKHD-only sites ('
p4040
aS'In view of the great increase of ARBS following the silencing of FOXA1 in the endogenous LNCaP system, we asked whether AR might be a direct target of FOXA1-mediated transcriptional repression'
p4041
aS'To determine whether this FOXA1 binding event leads to regulation of AR gene expression, QRT-PCR was carried out and showed that AR and KLK3 expression were indeed significantly increased following FOXA1 KD ('
p4042
aS'We first examined whether FOXA1 continues to inhibit AR in the absence of androgen.'
p4043
aS'QRT-PCR and western blot analysis demonstrated that FOXA1 KD in hormone-deprived LNCaP cells increased AR expression and led to significant upregulation of KLK3 transcript as well as protein ('
p4044
aS'To do this we categorized these ARBS into control-only, shFOXA1-only and shared, and examined these binding profiles in both androgen-deprived and androgen-stimulated conditions.'
p4045
aS'Heatmap view of ChIP-seq read intensity confirmed remarkable AR recruitment to the shFOXA1-only sites upon FOXA1 KD, despite a clear loss of FOXA1 binding ('
p4046
aS'To determine the AR-mediated transcriptional program, we carried out microarray analysis of control and FOXA1-KD LNCaP cells grown in androgen-depleted medium.'
p4047
aS'Previous studies have established a model wherein FOXA1 protein acts as a pioneering factor that interacts with and recruits AR to lineage-specific binding sites'
p4048
aS'Had FOXA1 not affected AR-chromatin binding, AR would have been relinquished to bind ARE motifs across the genome, which are not specific to prostate genes.'
p4049
aS'On the other hand, had FOXA1 directly recruited AR to the genome AR would potentially get recruited to all FOXA1 binding sites, which would ultimately dilute AR and inhibits AR-mediated activation of prostate-specific genes.'
p4050
aS'Our model, by contrast, showed that when FOXA1 is in equilibrium with AR, it opens up the chromatin to preferably facilitate AR co-occupancy at FKHD+ARE sites (high-affinity and highly accessible), but reduces AR binding to ARE-only sites (high affinity but not accessible).'
p4051
aS'Therefore, our study not only supports previously reported roles of FOXA1 in specifying lineage-specific AR program'
p4052
aS'In this study we have also shown that FOXA1 directly inhibits AR expression and thus the transcription of its target genes.'
p4053
aS'Interestingly, consistent with our results, a recent study has shown that FOXA1 overexpression largely inhibits AR target genes in PCa cells'
p4054
aS'Antibodies used in this study include anti-AR (06-680) from Millipore, anti-FOXA1 (ab23738), Histone H3 (ab1791) and anti-GAPDH (ab9385) from Abcam, anti-AR (sc-7305) from Santa Cruz, and anti-KLK3 (K2889-100UG) from Sigma ('
p4055
aS'Cells with coexpression of FOXA1(tagged with Flag) and AR (wild type or mutant) were lyzed in IP lysis buffer (50mM Tris-Cl pH7.4, 150mM NaCl, 1mM EDTA, 1% Triton X-100, Roche protease inhibitor cocktail).'
p4056
aS'Western blotting analysis were performed using rabbit anti-FOXA1(ab23738, Abcam) or rabbit anti-AR(06-680, Millipore).'
p4057
aS'AR and FOXA1 ChIP were carried out as described previously'
p4058
aS'In keeping with the role of PIAS1 as a SUMOylation pathway component, PIAS1, AR, and FOXA1 co-occurring genomic sites were also generally bound by SUMO2/3 and the binding of SUMO2/3 was markedly enhanced by androgen exposure (Figure '
p4059
aS'Androgen-enhanced co-occurrence of SUMO2/3 at AR-, PIAS1- and FOXA1-shared genomic locations.'
p4060
aS'Venn diagram showing the overlap of FOXA1, AR, and PIAS1 cistromes in cells exposed to androgen (upper panel).'
p4061
aS'ChIP-seq track examples of AR-, PIAS1-, FOXA1- and SUMO2/3-binding events in growth-associated AR target loci in VCaP cells.'
p4062
aS'Red bars below the tracks depict the positions of the identified peak sites and red arrows sites co-occupied by AR, PIAS1, FOXA1 and SUMO2/3.'
p4063
aS'FOXA1 depletion has been shown to elicit extensive redistribution of ARBs on prostate cancer cell chromatin ('
p4064
aS'PIAS1 was able to bind to chromatin, mainly at FOXA1 motif-containing sites in the absence of added androgen, but androgen exposure increased the number of PIAS1-binding sites markedly, resulting in practically complete overlap with about one tenth of the AR cistrome.'
p4065
aS'PIAS1 sites resulting from the androgen exposure showed enrichment for AREs and FOXA1 motifs at about the same frequency of 50%.'
p4066
aS'The genes associated with cell growth, apoptosis and cancer listed in the previous paragraph are prominent examples of AR-, PIAS1- and FOXA1-co-occupied enhancers.'
p4067
aS'In comparison to FOXA1 depletion which elicits extensive redistribution of ARBs on prostate cancer cell chromatin ('
p4068
aS'In line with the interaction of FOXA1 with PIAS1 as a SUMOylation pathway component, we have recently shown that FOXA1 is SUMOylated and that the modification modulates its activity and interaction with AR ('
p4069
aS'Androgen-bound ARs recruit PIAS1 to chromatin enhancer sites that are neighbored by FOXA1 and surrounded by active chromatin H3 methyl marks.'
p4070
aS'PIAS1 subsequently promotes SUMO2/3 (S2/3) modification of FOXA1 and/or AR and other factors, which also influences interactions with coregulator proteins (CoR).'
p4071
aS'However, there were significant differences in the enrichment of other transcription factor-binding motifs between the wtAR-preferred and the AR-SUMOylation mutant-preferred ARBs: motifs for pioneer transcription factor FOXA1 and C/EBP occurred more frequently among the wtAR-preferred ARBs, whereas AP-1 motif was more prevalent among the AR-2KR preferred ARBs.'
p4072
aS'The motif analyses thus imply that SUMOylation may influence the AR chromatin occupancy and target gene selection via regulating interactions with other sequence-specific transcription factors, such as FOXA1 and AP-1, which may enhance or weaken the AR binding to the chromatin.'
p4073
ag1497
as(S'POU2F1'
p4074
S'POU3F2'
p4075
S'increases'
p4076
tp4077
(lp4078
s(S'PCBP1'
p4079
S'MAZ'
p4080
S'increases'
p4081
tp4082
(lp4083
s(S'LEF1'
p4084
S'HOXA9'
p4085
S'increases'
p4086
tp4087
(lp4088
s(S'NR6A1'
p4089
S'CYP26A1'
p4090
S'increases'
p4091
tp4092
(lp4093
s(S'PI3K'
p4094
S'BTK'
p4095
S'translocates'
p4096
tp4097
(lp4098
s(S'AHR'
p4099
S'RUNX1'
p4100
S'increases'
p4101
tp4102
(lp4103
s(S'NR1H4'
p4104
S'CYP26A1'
p4105
S'increases'
p4106
tp4107
(lp4108
s(S'NR2F2'
p4109
S'CYP26A1'
p4110
S'increases'
p4111
tp4112
(lp4113
s(S'GNB1/GNG2'
p4114
S'PI3K'
p4115
S'binds'
p4116
tp4117
(lp4118
s(S'RHOA/GTP'
p4119
S'PKN2'
p4120
S'increases_activity'
p4121
tp4122
(lp4123
s(S'MAZ'
p4124
S'LEF1'
p4125
S'increases'
p4126
tp4127
(lp4128
s(S'RFX1'
p4129
S'MECOM'
p4130
S'increases'
p4131
tp4132
(lp4133
s(S'RUNX1'
p4134
S'HOXA9'
p4135
S'increases'
p4136
tp4137
(lp4138
s(S'FOXL1'
p4139
S'POU2F1'
p4140
S'increases'
p4141
tp4142
(lp4143
s(S'GRB2:SOS1'
p4144
S'PHOSPHORYLATED ERBB2:EGFR HETERODIMERS'
p4145
S'binds'
p4146
tp4147
(lp4148
s(S'TFAP4'
p4149
S'MYCN'
p4150
S'increases'
p4151
tp4152
(lp4153
s(S'E2F1'
p4154
S'GATA1'
p4155
S'increases'
p4156
tp4157
(lp4158
s(S'PTF1A'
p4159
S'GATA6'
p4160
S'increases'
p4161
tp4162
(lp4163
s(S'REL'
p4164
S'CYP26A1'
p4165
S'increases'
p4166
tp4167
(lp4168
s(S'MTF1'
p4169
S'JUN'
p4170
S'increases'
p4171
tp4172
(lp4173
s(S'ZEB1'
p4174
S'REPIN1'
p4175
S'increases'
p4176
tp4177
(lp4178
s(S'IRF8'
p4179
S'GATA6'
p4180
S'increases'
p4181
tp4182
(lp4183
s(S'P-Y349,350-SHC1:PHOSPHORYLATED ERBB2 HETERODIMERS'
p4184
S'GRB2:SOS1'
p4185
S'binds'
p4186
tp4187
(lp4188
s(S'BACH2'
p4189
S'EN1'
p4190
S'increases'
p4191
tp4192
(lp4193
s(S'GFI1'
p4194
S'MEIS1'
p4195
S'increases'
p4196
tp4197
(lp4198
s(S'FOXN1'
p4199
S'LEF1'
p4200
S'increases'
p4201
tp4202
(lp4203
s(S'CYP26A1'
p4204
S'JUN'
p4205
S'increases'
p4206
tp4207
(lp4208
s(S'TCF3'
p4209
S'ONECUT1'
p4210
S'increases'
p4211
tp4212
(lp4213
s(S'FOXF2'
p4214
S'POU2F1'
p4215
S'increases'
p4216
tp4217
(lp4218
s(S'MAZ'
p4219
S'MAX'
p4220
S'increases'
p4221
tp4222
(lp4223
s(S'FOXN1'
p4224
S'CYP26A1'
p4225
S'increases'
p4226
tp4227
(lp4228
s(S'HNF1A'
p4229
S'FOXD3'
p4230
S'increases'
p4231
tp4232
(lp4233
s(S'EGR2'
p4234
S'RUNX1'
p4235
S'increases'
p4236
tp4237
(lp4238
s(S'MYC'
p4239
S'RUNX2'
p4240
S'increases'
p4241
tp4242
(lp4243
s(S'TFAP2A'
p4244
S'IRF1'
p4245
S'increases'
p4246
tp4247
(lp4248
s(S'FOXO4'
p4249
S'YY1'
p4250
S'increases'
p4251
tp4252
(lp4253
s(S'VEGFR2 (dimer)/VEGFA (dimer)'
p4254
S'SRC'
p4255
S'adds_modification'
p4256
tp4257
(lp4258
s(S'resveratrol'
p4259
S'KRAS MRNA'
p4260
S'decreases'
p4261
tp4262
(lp4263
s(S'FOXO4'
p4264
S'CYP26A1'
p4265
S'increases'
p4266
tp4267
(lp4268
s(S'STAT3'
p4269
S'FOXO4'
p4270
S'increases'
p4271
tp4272
(lp4273
s(S'GRB2/SOS1'
p4274
S'FRS2 FAMILY/SHP2'
p4275
S'binds'
p4276
tp4277
(lp4278
s(S'LEF1'
p4279
S'CYP26A1'
p4280
S'increases'
p4281
tp4282
(lp4283
s(S'GTF2A2'
p4284
S'SRF'
p4285
S'increases'
p4286
tp4287
(lp4288
s(S'PPARA'
p4289
S'STAT5A'
p4290
S'increases'
p4291
tp4292
(lp4293
s(S'hsa-miR-143-3p'
p4294
S'KRAS'
p4295
S'decreases'
p4296
tp4297
(lp4298
s(S'GFI1'
p4299
S'CYP26A1'
p4300
S'increases'
p4301
tp4302
(lp4303
s(S'RAC1/GTP'
p4304
S'MKK4-MKK7'
p4305
S'increases_activity'
p4306
tp4307
(lp4308
s(S'REPIN1'
p4309
S'ETS1'
p4310
S'increases'
p4311
tp4312
(lp4313
s(S'ZIC1'
p4314
S'GATA6'
p4315
S'increases'
p4316
tp4317
(lp4318
s(S'INTERLEUKIN RECEPTOR COMPLEXES WITH ACTIVATED SHC1'
p4319
S'GRB2:SOS1'
p4320
S'binds'
p4321
tp4322
(lp4323
s(S'Selenium'
p4324
S'HRAS MRNA'
p4325
S'increases'
p4326
tp4327
(lp4328
s(S'HOXA4'
p4329
S'CYP26A1'
p4330
S'increases'
p4331
tp4332
(lp4333
s(S'NKX2-1'
p4334
S'POU2F1'
p4335
S'increases'
p4336
tp4337
(lp4338
s(S'VSX1'
p4339
S'MAX'
p4340
S'increases'
p4341
tp4342
(lp4343
s(S'FOXD1'
p4344
S'FOXD3'
p4345
S'increases'
p4346
tp4347
(lp4348
s(S'MAX'
p4349
S'NRAS'
p4350
S'increases'
p4351
tp4352
(lp4353
s(S'HOXA9'
p4354
S'TCF3'
p4355
S'increases'
p4356
tp4357
(lp4358
s(S'IRF1'
p4359
S'CYP26A1'
p4360
S'increases'
p4361
tp4362
(lp4363
s(S'HRAS'
p4364
S'RAF1'
p4365
S'adds_modification'
p4366
tp4367
(lp4368
s(S'CUX1'
p4369
S'HOXA9'
p4370
S'increases'
p4371
tp4372
(lp4373
s(S'ZHX2'
p4374
S'FOXA1'
p4375
S'increases'
p4376
tp4377
(lp4378
s(S'TFDP1'
p4379
S'MYC'
p4380
S'increases'
p4381
tp4382
(lp4383
s(S'RAC1/GTP'
p4384
S'PAK1'
p4385
S'increases_activity'
p4386
tp4387
(lp4388
s(S'AHR'
p4389
S'MAZ'
p4390
S'increases'
p4391
tp4392
(lp4393
s(S'BRAF/14-3-3'
p4394
S'KSR/14-3-3 /MEK1-2'
p4395
S'increases_activity'
p4396
tp4397
(lp4398
s(S'PPARA'
p4399
S'CYP26A1'
p4400
S'increases'
p4401
tp4402
(lp4403
s(S'REPIN1'
p4404
S'SRF'
p4405
S'increases'
p4406
tp4407
(lp4408
s(S'PAX5'
p4409
S'SRF'
p4410
S'increases'
p4411
tp4412
(lp4413
s(S'PAX4'
p4414
S'FOXJ2'
p4415
S'increases'
p4416
tp4417
(lp4418
s(S'REPIN1'
p4419
S'MYCN'
p4420
S'increases'
p4421
tp4422
(lp4423
s(S'RALA/GTP'
p4424
S'SRC'
p4425
S'adds_modification'
p4426
tp4427
(lp4428
s(S'FOXO4'
p4429
S'ETS1'
p4430
S'increases'
p4431
tp4432
(lp4433
s(S'TFDP1'
p4434
S'CDC5L'
p4435
S'increases'
p4436
tp4437
(lp4438
s(S'TFDP1'
p4439
S'CYP26A1'
p4440
S'increases'
p4441
tp4442
(lp4443
s(S'GATA6'
p4444
S'RUNX2'
p4445
S'increases'
p4446
tp4447
(lp4448
s(S'FOXM1'
p4449
S'CYP26A1'
p4450
S'increases'
p4451
tp4452
(lp4453
s(S'sodium arsenite'
p4454
S'HRAS PROTEIN'
p4455
S'increases'
p4456
tp4457
(lp4458
s(S'STAT5A'
p4459
S'RUNX1'
p4460
S'increases'
p4461
tp4462
(lp4463
s(S'CEBPA'
p4464
S'EN1'
p4465
S'increases'
p4466
tp4467
(lp4468
s(S'MSX1'
p4469
S'POU2F1'
p4470
S'increases'
p4471
tp4472
(lp4473
s(S'NHLH1'
p4474
S'CBFA2T3'
p4475
S'increases'
p4476
tp4477
(lp4478
s(S'Parathion'
p4479
S'HRAS PROTEIN'
p4480
S'increases'
p4481
tp4482
(lp4483
s(S'SMAD4'
p4484
S'CYP26A1'
p4485
S'increases'
p4486
tp4487
(lp4488
s(S'E2F1'
p4489
S'MYC'
p4490
S'increases'
p4491
tp4492
(lp4493
S'Oncogene TFs (MYC, MYB, E2F1, E2F3, E2F5, BCL6, ETS1 and STAT3) are shown as red circles.'
p4494
aS'The shared overlap of STAT3 binding in all four cell types forms a cell type-independent regulatory network with MYC and E2F1.'
p4495
as(S'CYP26A1'
p4496
S'FOXO3'
p4497
S'increases'
p4498
tp4499
(lp4500
s(S'TCF3'
p4501
S'CBFA2T3'
p4502
S'increases'
p4503
tp4504
(lp4505
s(S'ZHX2'
p4506
S'FOXF2'
p4507
S'increases'
p4508
tp4509
(lp4510
s(S'POU2F1'
p4511
S'MECOM'
p4512
S'increases'
p4513
tp4514
(lp4515
s(S'CYP26A1'
p4516
S'POU2F1'
p4517
S'increases'
p4518
tp4519
(lp4520
s(S'MYOD1'
p4521
S'CYP26A1'
p4522
S'increases'
p4523
tp4524
(lp4525
s(S'RAF'
p4526
S'COMPLEX (RAS/GTP)'
p4527
S'binds'
p4528
tp4529
(lp4530
s(S'RET51/GFRalpha1/GDNF/DOK1'
p4531
S'HRAS/GDP'
p4532
S'increases_activity'
p4533
tp4534
(lp4535
s(S'MAFG'
p4536
S'CYP26A1'
p4537
S'increases'
p4538
tp4539
(lp4540
s(S'CRX'
p4541
S'CYP26A1'
p4542
S'increases'
p4543
tp4544
(lp4545
s(S'hsa-miR-126-3p'
p4546
S'KRAS'
p4547
S'decreases'
p4548
tp4549
(lp4550
s(S'EBF2'
p4551
S'CYP26A1'
p4552
S'increases'
p4553
tp4554
(lp4555
s(S'RUNX1'
p4556
S'CYP26A1'
p4557
S'increases'
p4558
tp4559
(lp4560
s(S'HOXA5'
p4561
S'FOXA1'
p4562
S'increases'
p4563
tp4564
(lp4565
s(S'benzo(a)pyrene-3,6-quinone'
p4566
S'HRAS MRNA'
p4567
S'increases'
p4568
tp4569
(lp4570
s(S'K 7174'
p4571
S'HRAS MRNA'
p4572
S'decreases'
p4573
tp4574
(lp4575
s(S'LEF1'
p4576
S'NRAS'
p4577
S'increases'
p4578
tp4579
(lp4580
s(S'SPI1'
p4581
S'FOXA1'
p4582
S'increases'
p4583
tp4584
(lp4585
s(S'hsa-let-7b-5p'
p4586
S'NRAS'
p4587
S'decreases'
p4588
tp4589
(lp4590
s(S'CEBPA'
p4591
S'JUN'
p4592
S'increases'
p4593
tp4594
(lp4595
s(S'GABPB2'
p4596
S'CYP26A1'
p4597
S'increases'
p4598
tp4599
(lp4600
s(S'PI-3-4-5-P3'
p4601
S'MTOR'
p4602
S'increases_activity'
p4603
tp4604
(lp4605
s(S'GRB2:SOS1'
p4606
S'EGF:P-6Y-EGFR'
p4607
S'binds'
p4608
tp4609
(lp4610
s(S'HNF1A'
p4611
S'CYP26A1'
p4612
S'increases'
p4613
tp4614
(lp4615
s(S'HIF1A'
p4616
S'FOXO4'
p4617
S'increases'
p4618
tp4619
(lp4620
s(S'FOXJ1'
p4621
S'HOXA9'
p4622
S'increases'
p4623
tp4624
(lp4625
s(S'hsa-miR-96-5p'
p4626
S'KRAS'
p4627
S'decreases'
p4628
tp4629
(lp4630
s(S'SRC'
p4631
S'SYNDECAN-2/RASGAP'
p4632
S'binds'
p4633
tp4634
(lp4635
s(S'FOXA1'
p4636
S'MEIS1'
p4637
S'increases'
p4638
tp4639
(lp4640
s(S'LEF1'
p4641
S'MEIS1'
p4642
S'increases'
p4643
tp4644
(lp4645
s(S'PAX3'
p4646
S'CYP26A1'
p4647
S'increases'
p4648
tp4649
(lp4650
s(S'PAX4'
p4651
S'HOXA9'
p4652
S'increases'
p4653
tp4654
(lp4655
s(S'hsa-miR-18a-3p'
p4656
S'KRAS'
p4657
S'decreases'
p4658
tp4659
(lp4660
S'As a result, a total of two records from miRecords and miRTarBase show that hsa-miR-18a-3p targets KRAS (Figure '
p4661
as(S'FOXF2'
p4662
S'EN1'
p4663
S'increases'
p4664
tp4665
(lp4666
s(S'Pyk2'
p4667
S'SRC FAMILY KINASES'
p4668
S'increases_activity'
p4669
tp4670
(lp4671
s(S'TP53'
p4672
S'HOXA9'
p4673
S'increases'
p4674
tp4675
(lp4676
s(S'Genistein'
p4677
S'KRAS MRNA'
p4678
S'decreases'
p4679
tp4680
(lp4681
s(S'POU1F1'
p4682
S'CYP26A1'
p4683
S'increases'
p4684
tp4685
(lp4686
s(S'manumycin'
p4687
S'KRAS PROTEIN'
p4688
S'decreases_activity'
p4689
tp4690
(lp4691
s(S'Ginkgo biloba extract 761'
p4692
S'GCLC PROTEIN'
p4693
S'increases'
p4694
tp4695
(lp4696
s(S'GATA1'
p4697
S'NRAS'
p4698
S'increases'
p4699
tp4700
(lp4701
s(S'CBFA2T3'
p4702
S'FOXF2'
p4703
S'increases'
p4704
tp4705
(lp4706
s(S'PCBP1'
p4707
S'ELK1'
p4708
S'increases'
p4709
tp4710
(lp4711
s(S'MYC'
p4712
S'FOXF2'
p4713
S'increases'
p4714
tp4715
(lp4716
s(S'hsa-mir-622'
p4717
S'KRAS'
p4718
S'decreases'
p4719
tp4720
(lp4721
s(S'TCF3'
p4722
S'MAZ'
p4723
S'increases'
p4724
tp4725
(lp4726
s(S'STAT2'
p4727
S'MEIS1'
p4728
S'increases'
p4729
tp4730
(lp4731
s(S'CYP26A1'
p4732
S'YY1'
p4733
S'increases'
p4734
tp4735
(lp4736
s(S'CYP26A1'
p4737
S'EN1'
p4738
S'increases'
p4739
tp4740
(lp4741
s(S'GRB2/SOS1'
p4742
S'SHC'
p4743
S'binds'
p4744
tp4745
(lp4746
s(S'BAD'
p4747
S'YWHAZ'
p4748
S'binds'
p4749
tp4750
(lp4751
s(S'SPI1'
p4752
S'MAX'
p4753
S'increases'
p4754
tp4755
(lp4756
s(S'PI-3-4-5-P3'
p4757
S'CENTA1'
p4758
S'translocates'
p4759
tp4760
(lp4761
s(S'XBP1'
p4762
S'CYP26A1'
p4763
S'increases'
p4764
tp4765
(lp4766
s(S'PAX4'
p4767
S'NRAS'
p4768
S'increases'
p4769
tp4770
(lp4771
s(S'PI3K'
p4772
S'EPHRIN A1/EPHA2'
p4773
S'binds'
p4774
tp4775
(lp4776
s(S'POU1F1'
p4777
S'MEIS1'
p4778
S'increases'
p4779
tp4780
(lp4781
s(S'NR3C1'
p4782
S'ETS1'
p4783
S'increases'
p4784
tp4785
(lp4786
s(S'MAZ'
p4787
S'POU3F2'
p4788
S'increases'
p4789
tp4790
(lp4791
s(S'Estradiol'
p4792
S'HRAS MRNA'
p4793
S'increases'
p4794
tp4795
(lp4796
s(S'Aflatoxin B1'
p4797
S'HRAS PROTEIN'
p4798
S'increases'
p4799
tp4800
(lp4801
s(S'ETV7'
p4802
S'STAT4'
p4803
S'increases'
p4804
tp4805
(lp4806
s(S'PBX1'
p4807
S'LEF1'
p4808
S'increases'
p4809
tp4810
(lp4811
s(S'CEBPB'
p4812
S'CYP26A1'
p4813
S'increases'
p4814
tp4815
(lp4816
s(S'MAZ'
p4817
S'JUN'
p4818
S'increases'
p4819
tp4820
(lp4821
s(S'FOXF2'
p4822
S'MYC'
p4823
S'increases'
p4824
tp4825
(lp4826
s(S'FOXJ2'
p4827
S'HOXA9'
p4828
S'increases'
p4829
tp4830
(lp4831
s(S'Capsaicin'
p4832
S'HRAS MRNA'
p4833
S'increases'
p4834
tp4835
(lp4836
s(S'POU3F1'
p4837
S'GATA6'
p4838
S'increases'
p4839
tp4840
(lp4841
s(S'EIF2A'
p4842
S'14-3-3 E'
p4843
S'binds'
p4844
tp4845
(lp4846
s(S'RAS family/GTP'
p4847
S'RAF1-BRAF'
p4848
S'increases_activity'
p4849
tp4850
(lp4851
s(S'GATA6'
p4852
S'GATA1'
p4853
S'increases'
p4854
tp4855
(lp4856
s(S'RASA1'
p4857
S'PHOSPHO PDGF BETA RECEPTOR: PDGF CHAIN B HOMODIMER'
p4858
S'binds'
p4859
tp4860
(lp4861
s(S'CART1'
p4862
S'POU2F1'
p4863
S'increases'
p4864
tp4865
(lp4866
s(S'ZIC3'
p4867
S'POU2F1'
p4868
S'increases'
p4869
tp4870
(lp4871
s(S'TCF4'
p4872
S'FOXA1'
p4873
S'increases'
p4874
tp4875
(lp4876
s(S'PKC theta'
p4877
S'RASGRP1'
p4878
S'adds_modification'
p4879
tp4880
(lp4881
s(S'PTF1A'
p4882
S'STAT5A'
p4883
S'increases'
p4884
tp4885
(lp4886
s(S'SPI1'
p4887
S'FOXO4'
p4888
S'increases'
p4889
tp4890
(lp4891
s(S'HNF1A'
p4892
S'GATA6'
p4893
S'increases'
p4894
tp4895
(lp4896
s(S'FOXJ1'
p4897
S'RUNX1'
p4898
S'increases'
p4899
tp4900
(lp4901
s(S'STAT2'
p4902
S'GATA6'
p4903
S'increases'
p4904
tp4905
(lp4906
s(S'RAS FAMILY/GTP'
p4907
S'PI3K'
p4908
S'binds'
p4909
tp4910
(lp4911
s(S'PAX4'
p4912
S'IRF1'
p4913
S'increases'
p4914
tp4915
(lp4916
s(S'PAX3'
p4917
S'HOXA9'
p4918
S'increases'
p4919
tp4920
(lp4921
s(S'MYB'
p4922
S'MAZ'
p4923
S'increases'
p4924
tp4925
(lp4926
s(S"Guanosine-5'-Triphosphate"
p4927
S'HRAS'
p4928
S'increases_activity'
p4929
tp4930
(lp4931
s(S'alpha9/beta1 Integrin/Tenascin C'
p4932
S'SRC'
p4933
S'adds_modification'
p4934
tp4935
(lp4936
s(S'RAF1'
p4937
S'MEK1'
p4938
S'adds_modification'
p4939
tp4940
(lp4941
s(S'JUN'
p4942
S'FOXA1'
p4943
S'increases'
p4944
tp4945
(lp4946
s(S'NFE2L2'
p4947
S'BACH1'
p4948
S'increases'
p4949
tp4950
(lp4951
s(S'CUX1'
p4952
S'FOXD3'
p4953
S'increases'
p4954
tp4955
(lp4956
s(S'JUN'
p4957
S'EN1'
p4958
S'increases'
p4959
tp4960
(lp4961
s(S'ESR1'
p4962
S'CYP26A1'
p4963
S'increases'
p4964
tp4965
(lp4966
s(S'ESRRA'
p4967
S'FOXA1'
p4968
S'increases'
p4969
tp4970
(lp4971
s(S'POU2F1'
p4972
S'MEIS1'
p4973
S'increases'
p4974
tp4975
(lp4976
s(S'TFCP2'
p4977
S'FOXA1'
p4978
S'increases'
p4979
tp4980
(lp4981
s(S'PI-3-4-5-P3'
p4982
S'PDK1'
p4983
S'increases_activity'
p4984
tp4985
(lp4986
s(S'TCF3'
p4987
S'FOXA1'
p4988
S'increases'
p4989
tp4990
(lp4991
s(S'STAT3'
p4992
S'CYP26A1'
p4993
S'increases'
p4994
tp4995
(lp4996
s(S'CYP26A1'
p4997
S'POU3F2'
p4998
S'increases'
p4999
tp5000
(lp5001
s(S'Curcumin'
p5002
S'KRAS MRNA'
p5003
S'decreases'
p5004
tp5005
(lp5006
s(S'STAT1'
p5007
S'CYP26A1'
p5008
S'increases'
p5009
tp5010
(lp5011
s(S'GFI1'
p5012
S'POU2F1'
p5013
S'increases'
p5014
tp5015
(lp5016
s(S'ZIC1'
p5017
S'POU2F1'
p5018
S'increases'
p5019
tp5020
(lp5021
s(S'PI-3-4-5-P3'
p5022
S'AKT3'
p5023
S'adds_modification'
p5024
tp5025
(lp5026
s(S'BACH1'
p5027
S'NRAS'
p5028
S'increases'
p5029
tp5030
(lp5031
s(S'SCF/KIT'
p5032
S'SHC/GRB2/SOS1'
p5033
S'increases_activity'
p5034
tp5035
(lp5036
s(S'CDX2'
p5037
S'CYP26A1'
p5038
S'increases'
p5039
tp5040
(lp5041
s(S'RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK'
p5042
S'HRAS/GDP'
p5043
S'decreases_activity'
p5044
tp5045
(lp5046
s(S'BETAPIX'
p5047
S'RAC1/GTP'
p5048
S'binds'
p5049
tp5050
(lp5051
s(S'RHOA/GTP'
p5052
S'CITRON'
p5053
S'increases_activity'
p5054
tp5055
(lp5056
s(S'P-SHC1:GRB2:SOS'
p5057
S'P-5Y-LAT-2'
p5058
S'binds'
p5059
tp5060
(lp5061
s(S'PAX4'
p5062
S'CYP26A1'
p5063
S'increases'
p5064
tp5065
(lp5066
s(S'TCF3'
p5067
S'KRAS'
p5068
S'increases'
p5069
tp5070
(lp5071
s(S'GRB2:SOS1'
p5072
S'PHOSPHORYLATED ERBB2:ERBB4 HETERODIMERS'
p5073
S'binds'
p5074
tp5075
(lp5076
s(S'CDX2'
p5077
S'MEIS1'
p5078
S'increases'
p5079
tp5080
(lp5081
s(S'SP3'
p5082
S'RUNX1'
p5083
S'increases'
p5084
tp5085
(lp5086
s(S'REST'
p5087
S'CYP26A1'
p5088
S'increases'
p5089
tp5090
(lp5091
s(S'PTF1A'
p5092
S'CYP26A1'
p5093
S'increases'
p5094
tp5095
(lp5096
s(S'PI-3-4-5-P3'
p5097
S'PI3K/GAB1'
p5098
S'translocates'
p5099
tp5100
(lp5101
s(S'LMO2'
p5102
S'FOXO4'
p5103
S'increases'
p5104
tp5105
(lp5106
s(S'STAT4'
p5107
S'ETS1'
p5108
S'increases'
p5109
tp5110
(lp5111
s(S'GTF2A2'
p5112
S'HOXA9'
p5113
S'increases'
p5114
tp5115
(lp5116
s(S'FOXF2'
p5117
S'POU3F2'
p5118
S'increases'
p5119
tp5120
(lp5121
s(S'GATA1'
p5122
S'GABPB2'
p5123
S'increases'
p5124
tp5125
(lp5126
s(S'Polychlorinated Biphenyls'
p5127
S'KRAS MRNA'
p5128
S'decreases'
p5129
tp5130
(lp5131
s(S'GRB2/SOS1'
p5132
S'EGF/EGFR DIMER/SHC'
p5133
S'binds'
p5134
tp5135
(lp5136
s(S'CYP26A1'
p5137
S'FOXF2'
p5138
S'increases'
p5139
tp5140
(lp5141
s(S'EGR1'
p5142
S'CYP26A1'
p5143
S'increases'
p5144
tp5145
(lp5146
s(S'MAX'
p5147
S'FOXO3'
p5148
S'increases'
p5149
tp5150
(lp5151
s(S'T-DHT/AR/PELP1'
p5152
S'SRC'
p5153
S'binds'
p5154
tp5155
(lp5156
s(S'CUX1'
p5157
S'FOXF2'
p5158
S'increases'
p5159
tp5160
(lp5161
s(S'CEBPD'
p5162
S'CYP26A1'
p5163
S'increases'
p5164
tp5165
(lp5166
s(S'CBFA2T3'
p5167
S'NRAS'
p5168
S'increases'
p5169
tp5170
(lp5171
s(S'Cisplatin'
p5172
S'HRAS MRNA'
p5173
S'translocates'
p5174
tp5175
(lp5176
s(S'BAD/BCL-X(L)'
p5177
S'YWHAZ'
p5178
S'binds'
p5179
tp5180
(lp5181
s(S'GATA1'
p5182
S'FOXA1'
p5183
S'increases'
p5184
tp5185
(lp5186
s(S'RREB1'
p5187
S'CYP26A1'
p5188
S'increases'
p5189
tp5190
(lp5191
s(S'STAT4'
p5192
S'RUNX2'
p5193
S'increases'
p5194
tp5195
(lp5196
s(S'FOXD3'
p5197
S'NRAS'
p5198
S'increases'
p5199
tp5200
(lp5201
s(S'NDEL1'
p5202
S'14-3-3 E'
p5203
S'binds'
p5204
tp5205
(lp5206
s(S'CYP26A1'
p5207
S'REPIN1'
p5208
S'increases'
p5209
tp5210
(lp5211
s(S'MAF'
p5212
S'CDC5L'
p5213
S'increases'
p5214
tp5215
(lp5216
s(S'CYP26A1'
p5217
S'ELK1'
p5218
S'increases'
p5219
tp5220
(lp5221
s(S'MYC'
p5222
S'FOXD3'
p5223
S'increases'
p5224
tp5225
(lp5226
s(S'MAX'
p5227
S'FOXD3'
p5228
S'increases'
p5229
tp5230
(lp5231
s(S'POU1F1'
p5232
S'GATA6'
p5233
S'increases'
p5234
tp5235
(lp5236
s(S'POU2F1'
p5237
S'STAT4'
p5238
S'increases'
p5239
tp5240
(lp5241
s(S'GTF3A'
p5242
S'FOXO3'
p5243
S'increases'
p5244
tp5245
(lp5246
s(S'MYB'
p5247
S'FOXF2'
p5248
S'increases'
p5249
tp5250
(lp5251
s(S'ZIC3'
p5252
S'CYP26A1'
p5253
S'increases'
p5254
tp5255
(lp5256
s(S'POU2F1'
p5257
S'EN1'
p5258
S'increases'
p5259
tp5260
(lp5261
s(S'JUN'
p5262
S'STAT1'
p5263
S'increases'
p5264
tp5265
(lp5266
s(S'TEF'
p5267
S'CYP26A1'
p5268
S'increases'
p5269
tp5270
(lp5271
s(S'MAF'
p5272
S'CYP26A1'
p5273
S'increases'
p5274
tp5275
(lp5276
s(S'PAX4'
p5277
S'GATA6'
p5278
S'increases'
p5279
tp5280
(lp5281
s(S'ZIC2'
p5282
S'GATA6'
p5283
S'increases'
p5284
tp5285
(lp5286
s(S'hsa-miR-181d-5p'
p5287
S'HRAS'
p5288
S'decreases'
p5289
tp5290
(lp5291
s(S'BACH2'
p5292
S'CYP26A1'
p5293
S'increases'
p5294
tp5295
(lp5296
s(S'TCF12'
p5297
S'CYP26A1'
p5298
S'increases'
p5299
tp5300
(lp5301
s(S'GATA1'
p5302
S'FOXO4'
p5303
S'increases'
p5304
tp5305
(lp5306
s(S'RFX1'
p5307
S'FOXD3'
p5308
S'increases'
p5309
tp5310
(lp5311
s(S'FOXJ1'
p5312
S'CYP26A1'
p5313
S'increases'
p5314
tp5315
(lp5316
s(S'GTF2A2'
p5317
S'POU2F1'
p5318
S'increases'
p5319
tp5320
(lp5321
s(S'YY1'
p5322
S'SRF'
p5323
S'increases'
p5324
tp5325
(lp5326
g3303
aS'Functional interplay between SRF and YY1.'
p5327
aS'In the future, it would be valuable to perform ChIP-seq in the same cell line and conditions with antibodies for the coactivator specific TFs in this study (AP-1, AP-2, SP1, E2F and SRF, and YY1).'
p5328
as(S'AHR'
p5329
S'REPIN1'
p5330
S'increases'
p5331
tp5332
(lp5333
s(S'MAZ'
p5334
S'CYP26A1'
p5335
S'increases'
p5336
tp5337
(lp5338
s(S'Quercetin'
p5339
S'HRAS MRNA'
p5340
S'increases'
p5341
tp5342
(lp5343
s(S'ELK1'
p5344
S'NRAS'
p5345
S'increases'
p5346
tp5347
(lp5348
s(S'HIF1A'
p5349
S'ONECUT1'
p5350
S'increases'
p5351
tp5352
(lp5353
s(S'FOXF2'
p5354
S'CYP26A1'
p5355
S'increases'
p5356
tp5357
(lp5358
s(S'SOX9'
p5359
S'ETS1'
p5360
S'increases'
p5361
tp5362
(lp5363
s(S'HSF1'
p5364
S'JUN'
p5365
S'increases'
p5366
tp5367
(lp5368
s(S'CEBPA'
p5369
S'CYP26A1'
p5370
S'increases'
p5371
tp5372
(lp5373
s(S'NR1H4'
p5374
S'MEIS1'
p5375
S'increases'
p5376
tp5377
(lp5378
s(S'SMAD1'
p5379
S'GATA1'
p5380
S'increases'
p5381
tp5382
(lp5383
s(S'Quercetin'
p5384
S'HRAS MRNA'
p5385
S'decreases'
p5386
tp5387
(lp5388
s(S'Glycyrrhetinic Acid'
p5389
S'HRAS PROTEIN'
p5390
S'decreases'
p5391
tp5392
(lp5393
s(S'HOXA4'
p5394
S'POU2F1'
p5395
S'increases'
p5396
tp5397
(lp5398
s(S'FOXQ1'
p5399
S'CYP26A1'
p5400
S'increases'
p5401
tp5402
(lp5403
s(S'FOXI1'
p5404
S'CEBPA'
p5405
S'increases'
p5406
tp5407
(lp5408
s(S'GTF3A'
p5409
S'MYCN'
p5410
S'increases'
p5411
tp5412
(lp5413
s(S'LMO2'
p5414
S'IRF1'
p5415
S'increases'
p5416
tp5417
(lp5418
s(S'FOXO1'
p5419
S'CYP26A1'
p5420
S'increases'
p5421
tp5422
(lp5423
s(S'Copper Sulfate'
p5424
S'NRAS MRNA'
p5425
S'increases'
p5426
tp5427
(lp5428
s(S'TFAP2A'
p5429
S'CYP26A1'
p5430
S'increases'
p5431
tp5432
(lp5433
s(S'FOXJ1'
p5434
S'EN1'
p5435
S'increases'
p5436
tp5437
(lp5438
s(S'MEIS1'
p5439
S'RUNX1'
p5440
S'increases'
p5441
tp5442
(lp5443
s(S'MAZ'
p5444
S'FOXA1'
p5445
S'increases'
p5446
tp5447
(lp5448
s(S'ETS1'
p5449
S'FOXO4'
p5450
S'increases'
p5451
tp5452
(lp5453
s(S'ZBTB14'
p5454
S'FOXD3'
p5455
S'increases'
p5456
tp5457
(lp5458
s(S'FOXC1'
p5459
S'LEF1'
p5460
S'increases'
p5461
tp5462
(lp5463
s(S'IRF1'
p5464
S'EN1'
p5465
S'increases'
p5466
tp5467
(lp5468
s(S'NR3C1'
p5469
S'CYP26A1'
p5470
S'increases'
p5471
tp5472
(lp5473
s(S'VSX1'
p5474
S'BACH1'
p5475
S'increases'
p5476
tp5477
(lp5478
s(S'CYP26A1'
p5479
S'ETS1'
p5480
S'increases'
p5481
tp5482
(lp5483
s(S'CEBPA'
p5484
S'MEIS1'
p5485
S'increases'
p5486
tp5487
(lp5488
s(S'ELF1'
p5489
S'FOXO4'
p5490
S'increases'
p5491
tp5492
(lp5493
s(S'RXRA'
p5494
S'CYP26A1'
p5495
S'increases'
p5496
tp5497
(lp5498
s(S'CREB1'
p5499
S'CYP26A1'
p5500
S'increases'
p5501
tp5502
(lp5503
s(S'IRF7'
p5504
S'GATA6'
p5505
S'increases'
p5506
tp5507
(lp5508
s(S'ZEB1'
p5509
S'CYP26A1'
p5510
S'increases'
p5511
tp5512
(lp5513
s(S'AR'
p5514
S'CYP26A1'
p5515
S'increases'
p5516
tp5517
(lp5518
s(S'TFDP2'
p5519
S'MYC'
p5520
S'increases'
p5521
tp5522
(lp5523
s(S'hsa-mir-217'
p5524
S'KRAS'
p5525
S'decreases'
p5526
tp5527
(lp5528
s(S'MEK'
p5529
S'ERK'
p5530
S'adds_modification'
p5531
tp5532
(lp5533
S'Whereas WT MAVS signaling was inhibited by the JNK (SP600125), MEK and ERK (PD98059), and p38 (SB202190) inhibitors, '
p5534
aS'(a) Huh7 hepatocytes were treated with MAP kinase inhibitors targeting JNK (SP600125), MEK/ERK (PD98059) and p38 (SB202190).'
p5535
ag657
aS'Mutation of MAP3K5 or MAP3K9 results in decreased phospho-MEK/ERK and phospho-JNK compared to wild type proteins, indicating altered downstream signaling through multiple pathways.'
p5536
aS'Both scWesterns and conventional western blotting revealed dynamic, transient ERK and MEK phosphorylation responses ('
p5537
aS'MEK was activated within 5 min in response to FGF-2, followed closely by ERK, as expected ('
p5538
ag658
aS'MEK inhibition was assessed by stimulating bone marrow cells with GM-CSF and then measuring pERK levels by Western blotting ( also see '
p5539
aS'At baseline, COT expression increased ERK phosphorylation in a manner comparable to MEK1'
p5540
aS'To determine if COT might actively regulate MEK/ERK phosphorylation in B-RAF'
p5541
aS'Protein was transferred to PVDF membranes and probed with primary antibodies recognizing pERK1/2 (T202/Y204), pMEK1/2 (S217/221), MEK1/2, MEK1, MEK2, C-RAF (rabbit host), pC-RAF (pS338) (Cell Signaling Technology; 1:1,000), V5-HRP (Invitrogen; (1:5,000), COT (1:500), B-RAF (1:2,000), Actin (1:1,000), Actin-HRP (1:1,000; Santa Cruz)), C-RAF (mouse host; 1:1,000; BD Transduction Labs), Vinculin (Sigma; 1:20,000), AXL (1:500; R&D Systems).'
p5542
aS'MEK and ERK phosphorylation following treatment with DMSO or PLX4720 (concentration indicated).'
p5543
aS'ERK and MEK phosphorylation are quantified.'
p5544
aS'ERK and MEK phosphorylation in RPMI-7951 following 1 h. treatment with a small molecule COT kinase inhibitor.'
p5545
aS'ERK and MEK phosphorylation are quantified.'
p5546
aS'MEK and ERK phosphorylation in lysates from indicated cell lines treated with DMSO or CI-1040 (concentration noted).'
p5547
aS'Recombinant GST-ERK2, GST-MEK1, GST-ERK5, and GST-MEK5 proteins were expressed from pGEX-based vectors ('
p5548
aS'Resolved protein was transferred to nitrocellulose or PVDF membranes, blocked in LiCOR blocking buffer and probed with primary antibodies recognizing MITF (NeoMarkers, Clone C5, #MS-771-P, 1:400), Cyclin D1 (NeoMarkers, Clone Ab-3, #RB-010-P, 1:400), pERK1/2 (Thr202/Tyr204, Sigma, #M8159, 1:5,000), SLVR (Sigma, SAB4100050, 1:500), vinculin (Sigma, V9131, 1:20,000), total MEK1 (BD Transduction, #610122, 1:1000), acetylated histone H3 (Millipore, #06-599, 1:2000) and V5 epitope (Invitrogen, #R96025, 1:5,000).'
p5549
aS'Tumors with mutant BRAF are dependent on the RAF/MEK/ERK signaling pathway for their growth'
p5550
aS'MET is known to activate both the MAP kinase (MEK/ERK) and the PI-3-kinase (PI3K/AKT) pathways ('
p5551
ag660
aS'In order to determine whether MEK/ERK pathway hyperphosphorylation is functionally related to elevated depression-like behavior observed in CRF'
p5552
aS'Our results need to be discussed in the context of data demonstrating that chronic administration of antidepressants which increase the synaptic concentration of serotonin and/or norepinephrine, appear to activate the MEK/ERK signaling pathway in certain brain structures ('
p5553
aS'In NASH rats, the hepatic activities of PI3K/Akt, LKB1/AMPK and MEK/ERK were inhibited, whereas the activities of FoxO1 and JNK/c-Jun were induced.'
p5554
aS'Addition of LBP reversed the changes in the PI3K/Akt/FoxO1, LKB1/AMPK and JNK/c-Jun pathways but not in the MEK/ERK pathway ('
p5555
aS'To investigate whether MEK/ERK signaling contributes to TNFR1-promoted neurite growth from SCG neurons, we first tested whether TNFR1-Fc activates ERK1 and ERK2 in these neurons.'
p5556
aS'To investigate if ERK1/ERK2 activation is responsible for the enhanced neurite growth brought about by TNFR1-Fc, we examined whether U0126, a selective MEK1/MEK2 inhibitor that interferes with MEK1/MEK2 dependent activation of ERK1/ERK2 '
p5557
aS'Conversely, inhibition of the MEK/ERK or PLC pathways blocked import of Arc into the nucleus in response to a long BDNF treatment but did not affect BDNF-induced export ('
p5558
ag661
aS'HCC is characterized by frequent MEK/ERK activation in the absence of RAS or RAF mutation.'
p5559
aS'MEK: Mitogen-activated protein kinase/ERK kinase; TrkB: tropomyosin-receptor-kinase B.'
p5560
aS'MEK: Mitogen-activated protein kinase/ERK kinase; MMP: matrix metalloproteinases; BDNF: brain-derived neurotrophic factor.'
p5561
aS'TRK: Tyrosine receptor kinase; IGF-1R: insulin-like growth factor-1 receptor; MEK: mitogen-activated protein kinase kinase; ERK: extracellular signal-regulated kinase; PI-3K/Akt: phosphatidylinositol 3-kinases/protein kinase B.'
p5562
ag662
aS'Among these cascades, the rapidly accelerated fibrosarcoma (RAF)-mitogen-activated protein kinases (MEK)-extracellular signal-regulated kinases (ERK) pathway has been strongly implicated in axon growth signaling, while the PI3 kinase (PI3K)-AKT-mTOR pathway has been predominantly linked to anti-apoptotic and anabolic signaling.'
p5563
aS'In this study, two cell signaling pathway inhibitors, PD98059 and SB203580, were used to block the MEK-ERK and p38MAPK signaling pathways respectively.'
p5564
aS'Results demonstrated that at days 7, 14 and 28 after the MEK-ERK pathway was blocked, NSE gene and protein expression levels were decreased.'
p5565
aS'Evidence suggests that the MEK-ERK and p38MAPK signaling pathways are involved in apr-BYHWD-induced BMSC differentiation.'
p5566
aS'In summary, MEK-ERK and p38MAPK signaling pathways are involved in apr-BYHWD-induced BMSC differentiation into neurons.'
p5567
aS'Blocking MEK-ERK and p38MAPK signaling pathways can inhibit the effect of apr-BYHWD induction.'
p5568
ag663
aS'A recent study found that hyperforin activated different pathways, including Ras/MEK/ERK, PI3K/Akt and CAMKIV, causing cyclic adenosine monophosphate response element binding protein phosphorylation in PC12 cells and primary hippocampal neurons (Heiser et al., 2013).'
p5569
aS'The specific inhibition of MEK1, an upstream kinase of ERK1/2, abrogates the ability of LPS to prevent apoptosis but does not impact the DC maturation, which suggests that ERK1/2 signaling pathway may mainly maintain DC survival ['
p5570
aS'In the next, we treated the cells with PD98059 (a MEK inhibitor) to block the ERK1/2-mediated positive regulation of the incoherent feed-forward loop.'
p5571
ag665
aS'The Ras/MEK/ERK signalling cascade is key pathway implicated in hematopoietic malignant cells survival signalling.'
p5572
aS'In summary, our data demonstrate a role for MLKs as direct activators of the MEK/ERK pathway with implications for melanomagenesis and resistance to RAF inhibitors.'
p5573
aS'Aberrant activation of the MEK/ERK pathway leads to tumorigenesis and the role of mutationally activated BRAF as a driver of metastatic melanoma has been well established'
p5574
aS'Based on our proposed mechanism whereby MLKs can activate the MEK/ERK pathway in a manner independent of the RAF kinases, we sought to determine whether MLKs may mediate reactivation of this pathway in the presence of RAF inhibitors in V600E-positive melanoma cells.'
p5575
aS'We observed that expression of MLKs reactivated the MEK/ERK pathway in the presence of vemurafenib in a kinase-dependent manner ('
p5576
aS'These data provide a new layer of complexity in regards to MAPK signalling; we have shown that the MLKs are not only able to phosphorylate MKK4/7 to regulate the JNK pathway, but also MEK1/2 to regulate the ERK pathway.'
p5577
aS'It was previously reported that MLK3 acts as a scaffold for BRAF to activate the MEK/ERK pathway; however, our data demonstrate that the MLKs act directly at the level of MEK, and through phosphorylation of MEK can activate ERK.'
p5578
aS'Much remains to be determined regarding the nature of when and how the MLKs regulate the MEK/ERK pathway and future studies should reveal exciting revelations regarding the molecular mechanisms important for differential regulation of downstream components.'
p5579
aS'Resistance generally occurs through reactivation of the MEK/ERK pathway, although activation of the PI3K/AKT pathway by receptor tyrosine kinase upregulation'
p5580
aS'Primary antibodies: p-ERK1/2 (T202/Y204), p-MEK (S217/221), ERK1/2, MEK, p-MKK4 (S257/T261), p-MKK7 (S271/T275), MKK4, p-JNK (T183/Y185), JNK, MLK1, PARP, XIAP, cleaved caspase-3 (Cell Signaling Technology), MLK2, MLK3 (Epitomics), MLK4 (Bethyl), HA (Covance), Tubulin, Flag M2 (Sigma) and BRAF (Santa Cruz).'
p5581
ag666
aS'To address this issue, we purified GST-Araf that was expressed and activated by FGF2 treatment in HEK293T cells in the absence or presence of the MEK inhibitor PD98059 or the ERK inhibitor EIP I.'
p5582
aS'The addition of the inhibitor would prevent contamination of activated MEKs or ERKs in the purified GST-Araf.'
p5583
aS'As the LAMTOR complex is crucial for the activation of MEK/ERK and mTORC1 on late endosomes and deletion of '
p5584
aS'We validated the network approach for identification of markers for Alveolar type 2 cells using antibodies to PEBP4, a RAF kinase inhibitory protein (RKIP) family member and a scaffold protein controlling myoblast and muscle cell differentiation through MEK and ERK signaling'
p5585
aS'ERK and its upstream kinase MEK localize to the extra-luminal face of autophagosomes.'
p5586
aS'Immunofluorescence in NIH/3T3 cells revealed increased colocalization of ERK cascade components, P-bRAF, P-MEK and P-ERK with LC3-II ('
p5587
aS'P-MEK and P-ERK colocalized with LC3-II in hypothalamic cells ('
p5588
aS'To determine whether MEK and ERK associate with LC3-II-positive autophagic structures '
p5589
aS'P-ERK1, P-ERK2, P-ERK1/2 or P-MEK1/2 bands obtained by immunoblotting were quantified using ImageJ and normalized to corresponding total ERK1, total ERK2, total ERK1/2 or total MEK1/2, respectively.'
p5590
ag667
aS'Importantly, this conclusion is not restricted to transformed keratinocytes, as EGF-mediated Src, -MEK1, -ERK1/2 and -STAT3 phosphorylations were also severely impaired on KIAA1199 deficiency in breast cancer-derived MCF7 and SK-BR-3 cells, as well as in immortalized breast epithelial NMuMG cells ('
p5591
aS'As such, KIAA1199 critically controls EGF-mediated EMT through the Ras/MEK1/ERK1/2 pathway ('
p5592
aS'Anti-Slug, -pMEK1 (S217/221), -Src, -pScr (Y416), -c-Cbl, -pSTAT3, -pERK1/2, -EGFR, -HER2, -HER3 and -pEGFR (T669, Y845, Y1045 and Y1068) antibodies were from Cell Signaling.'
p5593
aS'First we examined the effect of PEA-15 binding on ERK2 activation by its upstream kinase MEK1 ('
p5594
aS'Activation of ERK2 by MEK1 '
p5595
ag668
ag669
aS'The obvious strategy is blocking a never gene and both MEK and ERK inhibitors are under investigation ('
p5596
aS'When the macrophages were pretreated with MEK/ERK inhibitor PD98059, the effects of RasGRP3 knockdown on IL-6 production were reversed ('
p5597
aS'It also highlights that a yet unidentified FGF-2-dependent, MEK/ERK-mediated signalling event underlies hnRNPA1 nuclear exit.'
p5598
ag670
ag671
aS'Our screening also identified the MAPK/ERK kinase 5 (MEK5) as a potential modulator of nurr1 activity (Supplementary Table 1).'
p5599
aS'In summary, using our screening methodology we have identified signaling cascades that regulate nurr1 activity (ERK2, LIMK1 and MEK5/ERK5) as well as potential functional partners of nurr1 in transcription and survival/apoptosis.'
p5600
aS'Nurr1 transcriptional activity is regulated by the MEK5/ERK5 signaling pathway.'
p5601
aS'The RAS/RAF/MEK/ERK (RAS/ERK) pathway is activated by many growth factors and regulates cellular proliferation, survival and motility.'
p5602
aS'Repressing the RAS/ERK pathway by the MEK inhibitor U0126 decreased reporter expression about 50% (Figure '
p5603
aS'To test if ETS1 regulates expression of the same genes that are activated by RAS/ERK signaling, DU145 cells were treated with the MEK inhibitor U0126, and mRNA levels were measured in triplicate by RNA-seq (Gene expression changes are detailed in Supplementary Table S3).'
p5604
aS'The MEK1-ERK1/2 pathway is not affecting NFATc1 subcellular localization.'
p5605
ag672
aS'The three MAPK pathways are regulated by different upstream components: ERK1/2 by MAP/extracellular-regulated kinase1/2 (MEK1/2); p38 by protein kinase R (PKR); and JNK by MEK1/4 ('
p5606
aS'PEA3 is sufficient to enhance the activity of this reporter construct but this activity is substantially increased by either co-expression of a constitutively active form of MEK to activate the ERK pathway or the acetyl transferase p300 ('
p5607
ag673
aS'To further examine the PDGF signaling on LamB1 IRES translation, we selectively inhibited PI3K/AKT or MAPK/ERK signaling in EMT-transformed MIM-RT cells using small molecule inhibitors targeting PI3K or MEK1/2.'
p5608
aS'Significantly, antagonism of the MEK/ERK pathway strongly reversed the effects both of angiotensin and capsaicin.'
p5609
aS'The mechanistic linkage of two important regulators of neurogenic inflammation, the MEK/ERK pathway and the TAC1 gene, using comparative genomics indicates a future direction for understanding the interactions of the signal transduction systems and genomic sequences involved in modulating disease-related genes.'
p5610
aS'The MAPKinases are divided into 3 distinct pathways: p38, JNK and MEK/ERK.'
p5611
aS'In order to determine which of these pathways is responsible for the upregulation of ECR2-TAC1prom synergy by angiotensin, we transfected primary sensory neurones with the ECR2-TAC1prom-Luc construct and incubated them in the presence of angiotensin and antagonists of the JNK (SP600125), p38 (SB202190) and MEK/ERK (PD98059) pathways.'
p5612
aS'Only PD98059 was able to significantly reverse the effects of angiotensin on the ECR2-TAC1prom-Luc construct, suggesting that MAPK control of ECR2-TAC1prom is modulated by the MEK/ERK pathway (fig. '
p5613
aS'In order to address this possibility we transfected primary DRG neurones with the ECR2-TAC1prom-Luc plasmid and cultured them in the presence of capsaicin or capsaicin plus the MEK/ERK antagonist PD98059.'
p5614
aS'The significant upregulation of ECR2-TAC1-Luc activity observed following treatment with the antagonist SB202190 suggests that p38MAPK may play a role in antagonising the influence of MEK/ERK on the TAC1 gene.'
p5615
aS'The HFS-induced activation of ERK-driven transcriptional regulation in MGm/PIN neurons is consistent with previous work that has shown that infusion of a MEK inhibitor into the MGm/PIN impairs LTP in the LA ['
p5616
aS'Our findings of enhanced activation of ERK-driven transcriptional regulation in both LA and MGm/PIN neurons is consistent with previous work that has shown that infusion of a MEK inhibitor into either the LA or the MGm/PIN impairs LTP in the LA ['
p5617
aS'Most importantly, this requires MEK-dependent ERK phosphorylation.'
p5618
aS'The signaling complex core is c-Src and its binding\npartners include PKC delta, epsilon and alpha, Ras, MEK1/2,\nERK1/2, tubulin, FAK, paxillin, vinculin, caveolin-1, KSR-\n1 and the GnRHR.'
p5619
aS'A short exposure to GnRH (5 minutes)\ncauses MEK1/2, ERK1/2, tubulin, vinculin, and the Gn-\nRHR to detach from c-Src followed by reassociation with\nthe complex by 30minutes.'
p5620
aS'Pharmacological analysis showed that\nRSK2 induction was MAPK ERK Kinase (MEK)-ERK independent,\nbut mammalian Target of Rapamycin (mTOR) and\ntranslation dependent.'
p5621
aS'MEK/ERK pathway phosphorylates c-myc on Serine 62, which stabilizes c-myc by preventing ubiquitin/proteasomal degradation '
p5622
aS'Dependence of NE-induced proliferation upon PI3K was demonstrated using an inhibitor (LY294002), whereas inhibition of the MEK/ERK pathway (U0126) had no effect ('
p5623
as(S'ZBTB18'
p5624
S'ONECUT1'
p5625
S'increases'
p5626
tp5627
(lp5628
s(S'TGIF'
p5629
S'MAX'
p5630
S'increases'
p5631
tp5632
(lp5633
s(S'ETS1'
p5634
S'NRAS'
p5635
S'increases'
p5636
tp5637
(lp5638
s(S'KLF12'
p5639
S'GATA1'
p5640
S'increases'
p5641
tp5642
(lp5643
s(S'HRAS/GTP'
p5644
S'PAK2'
p5645
S'increases_activity'
p5646
tp5647
(lp5648
s(S'CYP26A1'
p5649
S'FOXD3'
p5650
S'increases'
p5651
tp5652
(lp5653
s(S'LMO2'
p5654
S'RUNX1'
p5655
S'increases'
p5656
tp5657
(lp5658
s(S'MLK3'
p5659
S'MKK3/6'
p5660
S'adds_modification'
p5661
tp5662
(lp5663
s(S'TAK'
p5664
S'MKK3/6'
p5665
S'adds_modification'
p5666
tp5667
(lp5668
s(S'GRB2:SOS1'
p5669
S'HB-EGF:P-6Y-EGFR DIMER'
p5670
S'binds'
p5671
tp5672
(lp5673
s(S'FOXO4'
p5674
S'NRAS'
p5675
S'increases'
p5676
tp5677
(lp5678
s(S'MECOM'
p5679
S'NRAS'
p5680
S'increases'
p5681
tp5682
(lp5683
s(S'KLF12'
p5684
S'CYP26A1'
p5685
S'increases'
p5686
tp5687
(lp5688
s(S'RAS family/GTP/PI3K'
p5689
S'TRPV1'
p5690
S'adds_modification'
p5691
tp5692
(lp5693
s(S'hsa-let-7a-5p'
p5694
S'NRAS'
p5695
S'decreases'
p5696
tp5697
(lp5698
s(S'NF1'
p5699
S'HOXA9'
p5700
S'increases'
p5701
tp5702
(lp5703
s(S'REPIN1'
p5704
S'FOXD3'
p5705
S'increases'
p5706
tp5707
(lp5708
s(S'CYP26A1'
p5709
S'FOXJ2'
p5710
S'increases'
p5711
tp5712
(lp5713
s(S'FOXO4'
p5714
S'MEIS1'
p5715
S'increases'
p5716
tp5717
(lp5718
s(S'EBF2'
p5719
S'MECOM'
p5720
S'increases'
p5721
tp5722
(lp5723
s(S'ETS1'
p5724
S'FOXO3'
p5725
S'increases'
p5726
tp5727
(lp5728
s(S'SP3'
p5729
S'CYP26A1'
p5730
S'increases'
p5731
tp5732
(lp5733
s(S'LNXp80'
p5734
S'NUMB'
p5735
S'decreases'
p5736
tp5737
(lp5738
s(S'RUNX2'
p5739
S'CYP26A1'
p5740
S'increases'
p5741
tp5742
(lp5743
s(S'AHR'
p5744
S'FOXO3'
p5745
S'increases'
p5746
tp5747
(lp5748
s(S'VSX1'
p5749
S'FOXF2'
p5750
S'increases'
p5751
tp5752
(lp5753
s(S'BPTF'
p5754
S'RUNX1'
p5755
S'increases'
p5756
tp5757
(lp5758
s(S'7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide'
p5759
S'HRAS PROTEIN'
p5760
S'increases'
p5761
tp5762
(lp5763
s(S'TCF3'
p5764
S'POU3F2'
p5765
S'increases'
p5766
tp5767
(lp5768
s(S'TCF3'
p5769
S'IRF1'
p5770
S'increases'
p5771
tp5772
(lp5773
s(S'SREBF1'
p5774
S'EN1'
p5775
S'increases'
p5776
tp5777
(lp5778
s(S'FOXO4'
p5779
S'RUNX2'
p5780
S'increases'
p5781
tp5782
(lp5783
s(S'hsa-miR-181a-5p'
p5784
S'HRAS'
p5785
S'decreases'
p5786
tp5787
(lp5788
s(S'Myb'
p5789
S'NRAS'
p5790
S'decreases'
p5791
tp5792
(lp5793
s(S'HSPA8'
p5794
S'ADP'
p5795
S'binds'
p5796
tp5797
(lp5798
s(S'SOCS3'
p5799
S'RASGAP'
p5800
S'binds'
p5801
tp5802
(lp5803
s(S'ONECUT1'
p5804
S'NRAS'
p5805
S'increases'
p5806
tp5807
(lp5808
s(S'PITX2'
p5809
S'EN1'
p5810
S'increases'
p5811
tp5812
(lp5813
s(S'HGF(dimer)/MET(dimer)'
p5814
S'SRC'
p5815
S'adds_modification'
p5816
tp5817
(lp5818
s(S'2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine'
p5819
S'HRAS PROTEIN'
p5820
S'increases'
p5821
tp5822
(lp5823
s(S'GFI1'
p5824
S'POU3F2'
p5825
S'increases'
p5826
tp5827
(lp5828
s(S'FARNESYL DIPHOSPHATE'
p5829
S'KRAS'
p5830
S'increases_activity'
p5831
tp5832
(lp5833
s(S'IL2/IL2R BETA/GAMMA/JAK1/LCK/JAK3'
p5834
S'PI3K'
p5835
S'binds'
p5836
tp5837
(lp5838
s(S'GTF3A'
p5839
S'MECOM'
p5840
S'increases'
p5841
tp5842
(lp5843
s(S'EGR2'
p5844
S'CYP26A1'
p5845
S'increases'
p5846
tp5847
(lp5848
s(S'RUNX1'
p5849
S'FOXF2'
p5850
S'increases'
p5851
tp5852
(lp5853
s(S'IL3/IL3RA/CSF2RB (DODECAMER)'
p5854
S'YWHAZ'
p5855
S'binds'
p5856
tp5857
(lp5858
s(S'RAF1'
p5859
S'BRAF'
p5860
S'binds'
p5861
tp5862
(lp5863
s(S'MYC'
p5864
S'CYP26A1'
p5865
S'increases'
p5866
tp5867
(lp5868
s(S'UBP1'
p5869
S'CYP26A1'
p5870
S'increases'
p5871
tp5872
(lp5873
s(S'MTF1'
p5874
S'REPIN1'
p5875
S'increases'
p5876
tp5877
(lp5878
s(S'HNF1A'
p5879
S'RUNX1'
p5880
S'increases'
p5881
tp5882
(lp5883
s(S'NHLH1'
p5884
S'FOXA1'
p5885
S'increases'
p5886
tp5887
(lp5888
s(S'HLF'
p5889
S'FOXA1'
p5890
S'increases'
p5891
tp5892
(lp5893
s(S'MEIS1'
p5894
S'GATA6'
p5895
S'increases'
p5896
tp5897
(lp5898
s(S'PDGF-BB/PDGFRB (DIMER)/SHP2'
p5899
S'GRB2/SOS1'
p5900
S'binds'
p5901
tp5902
(lp5903
s(S'ZBTB14'
p5904
S'EN1'
p5905
S'increases'
p5906
tp5907
(lp5908
s(S'alpha6/beta4 Integrin'
p5909
S'HRAS/GDP'
p5910
S'increases_activity'
p5911
tp5912
(lp5913
s(S'ErbB2'
p5914
S'HRAS/GDP'
p5915
S'increases_activity'
p5916
tp5917
(lp5918
s(S'MEIS1'
p5919
S'FOXO3'
p5920
S'increases'
p5921
tp5922
(lp5923
s(S'RELA'
p5924
S'IRF1'
p5925
S'increases'
p5926
tp5927
(lp5928
s(S'MYCN'
p5929
S'FOXO3'
p5930
S'increases'
p5931
tp5932
(lp5933
s(S'RHOA/GTP'
p5934
S'DIA'
p5935
S'increases_activity'
p5936
tp5937
(lp5938
s(S'Fluorouracil'
p5939
S'KRAS PROTEIN'
p5940
S'decreases'
p5941
tp5942
(lp5943
s(S'ATF2'
p5944
S'CYP26A1'
p5945
S'increases'
p5946
tp5947
(lp5948
s(S'GNAI2/GTP'
p5949
S'SRC FAMILY KINASES'
p5950
S'increases_activity'
p5951
tp5952
(lp5953
s(S'HAND1'
p5954
S'POU2F1'
p5955
S'increases'
p5956
tp5957
(lp5958
s(S'PI5K Type 1 family'
p5959
S'PI-4-P'
p5960
S'translocates'
p5961
tp5962
(lp5963
s(S'HSF1'
p5964
S'CBFA2T3'
p5965
S'increases'
p5966
tp5967
(lp5968
s(S'BACH1'
p5969
S'FOXA1'
p5970
S'increases'
p5971
tp5972
(lp5973
s(S'PI-3-4-5-P3'
p5974
S'SGK1'
p5975
S'adds_modification'
p5976
tp5977
(lp5978
s(S'hsa-miR-20a-5p'
p5979
S'NRAS'
p5980
S'decreases'
p5981
tp5982
(lp5983
s(S'CYP26A1'
p5984
S'MECOM'
p5985
S'increases'
p5986
tp5987
(lp5988
s(S'FOXF2'
p5989
S'RUNX1'
p5990
S'increases'
p5991
tp5992
(lp5993
s(S'EGR2'
p5994
S'SRF'
p5995
S'increases'
p5996
tp5997
(lp5998
s(S'LEF1'
p5999
S'FOXD3'
p6000
S'increases'
p6001
tp6002
(lp6003
s(S'TFAP2C'
p6004
S'MECOM'
p6005
S'increases'
p6006
tp6007
(lp6008
s(S'SHC'
p6009
S'GRB2/SOS1'
p6010
S'binds'
p6011
tp6012
(lp6013
s(S'CA2+'
p6014
S'CAM'
p6015
S'binds'
p6016
tp6017
(lp6018
s(S'MYC'
p6019
S'POU3F2'
p6020
S'increases'
p6021
tp6022
(lp6023
s(S'PAX8'
p6024
S'HOXA9'
p6025
S'increases'
p6026
tp6027
(lp6028
s(S'TFDP2'
p6029
S'CDC5L'
p6030
S'increases'
p6031
tp6032
(lp6033
s(S'RAF1/14-3-3'
p6034
S'KSR/14-3-3 /MEK1-2'
p6035
S'increases_activity'
p6036
tp6037
(lp6038
s(S'DDIT3'
p6039
S'MEIS1'
p6040
S'increases'
p6041
tp6042
(lp6043
s(S'GNB1/GNG2'
p6044
S'HRAS/GDP'
p6045
S'increases_activity'
p6046
tp6047
(lp6048
s(S'ACTIVATED FGFR MUTANTS:P-FRS2ALPHA'
p6049
S'GRB2:SOS1'
p6050
S'binds'
p6051
tp6052
(lp6053
s(S'HIF1A'
p6054
S'CYP26A1'
p6055
S'increases'
p6056
tp6057
(lp6058
s(S'RAF1-BRAF'
p6059
S'ERK1-2'
p6060
S'increases_activity'
p6061
tp6062
(lp6063
s(S'SMAD4'
p6064
S'CBFA2T3'
p6065
S'increases'
p6066
tp6067
(lp6068
s(S'resveratrol'
p6069
S'HRAS PROTEIN'
p6070
S'increases'
p6071
tp6072
(lp6073
s(S'Malathion'
p6074
S'HRAS MRNA'
p6075
S'increases'
p6076
tp6077
(lp6078
s(S'NRF1'
p6079
S'FOXO4'
p6080
S'increases'
p6081
tp6082
(lp6083
s(S'CREB1'
p6084
S'JUN'
p6085
S'increases'
p6086
tp6087
(lp6088
s(S'CDC5L'
p6089
S'HOXA9'
p6090
S'increases'
p6091
tp6092
(lp6093
s(S'CDX2'
p6094
S'HOXA9'
p6095
S'increases'
p6096
tp6097
(lp6098
s(S'HMGA1'
p6099
S'POU2F1'
p6100
S'increases'
p6101
tp6102
(lp6103
s(S'Coumestrol'
p6104
S'KRAS MRNA'
p6105
S'decreases'
p6106
tp6107
(lp6108
s(S'LEF1'
p6109
S'FOXO3'
p6110
S'increases'
p6111
tp6112
(lp6113
s(S'CYP26A1'
p6114
S'MEIS1'
p6115
S'increases'
p6116
tp6117
(lp6118
s(S'GTF2A2'
p6119
S'MEIS1'
p6120
S'increases'
p6121
tp6122
(lp6123
s(S'REPIN1'
p6124
S'CBFA2T3'
p6125
S'increases'
p6126
tp6127
(lp6128
s(S'hsa-miR-143-3p'
p6129
S'HRAS'
p6130
S'decreases'
p6131
tp6132
(lp6133
s(S'[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID'
p6134
S'KRAS'
p6135
S'increases_activity'
p6136
tp6137
(lp6138
s(S'TFDP1'
p6139
S'ONECUT1'
p6140
S'increases'
p6141
tp6142
(lp6143
s(S'YY1'
p6144
S'CYP26A1'
p6145
S'increases'
p6146
tp6147
(lp6148
s(S'PITX2'
p6149
S'RUNX1'
p6150
S'increases'
p6151
tp6152
(lp6153
s(S'STAT5A'
p6154
S'NRAS'
p6155
S'increases'
p6156
tp6157
(lp6158
s(S'Valproic Acid'
p6159
S'HRAS MRNA'
p6160
S'increases'
p6161
tp6162
(lp6163
s(S'Malathion'
p6164
S'HRAS PROTEIN'
p6165
S'increases'
p6166
tp6167
(lp6168
s(S'TFAP4'
p6169
S'CBFA2T3'
p6170
S'increases'
p6171
tp6172
(lp6173
s(S'TFAP4'
p6174
S'EN1'
p6175
S'increases'
p6176
tp6177
(lp6178
s(S'POU3F2'
p6179
S'CYP26A1'
p6180
S'increases'
p6181
tp6182
(lp6183
s(S'PAX3'
p6184
S'FOXD3'
p6185
S'increases'
p6186
tp6187
(lp6188
s(S'FOXA2'
p6189
S'RUNX2'
p6190
S'increases'
p6191
tp6192
(lp6193
s(S'MAX'
p6194
S'BACH1'
p6195
S'increases'
p6196
tp6197
(lp6198
s(S'PDX1'
p6199
S'CYP26A1'
p6200
S'increases'
p6201
tp6202
(lp6203
s(S'EPO/EPOR (dimer)/JAK2'
p6204
S'SHC/GRB2/SOS1'
p6205
S'increases_activity'
p6206
tp6207
(lp6208
s(S'E2F1'
p6209
S'MEIS1'
p6210
S'increases'
p6211
tp6212
(lp6213
s(S'FOXF2'
p6214
S'MEIS1'
p6215
S'increases'
p6216
tp6217
(lp6218
s(S'SPZ1'
p6219
S'FOXJ2'
p6220
S'increases'
p6221
tp6222
(lp6223
s(S'SRY'
p6224
S'NRAS'
p6225
S'increases'
p6226
tp6227
(lp6228
s(S'REPIN1'
p6229
S'CYP26A1'
p6230
S'increases'
p6231
tp6232
(lp6233
s(S'VEGFR3/VEGFC-D'
p6234
S'PKC'
p6235
S'increases_activity'
p6236
tp6237
(lp6238
s(S'MEIS1'
p6239
S'EN1'
p6240
S'increases'
p6241
tp6242
(lp6243
s(S'FOXJ1'
p6244
S'FOXD3'
p6245
S'increases'
p6246
tp6247
(lp6248
s(S'SPZ1'
p6249
S'FOXO4'
p6250
S'increases'
p6251
tp6252
(lp6253
s(S'RHOA/GTP'
p6254
S'ROCK1-ROCK2'
p6255
S'increases_activity'
p6256
tp6257
(lp6258
s(S'HMGA1'
p6259
S'ONECUT1'
p6260
S'increases'
p6261
tp6262
(lp6263
s(S'uPA/uPAR/alphav/beta3 Integrin/Vitronectin'
p6264
S'SRC'
p6265
S'adds_modification'
p6266
tp6267
(lp6268
s(S'ETS1'
p6269
S'CYP26A1'
p6270
S'increases'
p6271
tp6272
(lp6273
s(S'ESRRA'
p6274
S'TLX2'
p6275
S'increases'
p6276
tp6277
(lp6278
s(S'ROCK2'
p6279
S'RHO FAMILY GTPASE-ACTIVE'
p6280
S'binds'
p6281
tp6282
(lp6283
s(S'ATF4'
p6284
S'CYP26A1'
p6285
S'increases'
p6286
tp6287
(lp6288
s(S'OR5I1'
p6289
S'CYP26A1'
p6290
S'increases'
p6291
tp6292
(lp6293
s(S'PITX2'
p6294
S'GATA1'
p6295
S'increases'
p6296
tp6297
(lp6298
s(S'AHR'
p6299
S'ONECUT1'
p6300
S'increases'
p6301
tp6302
(lp6303
s(S'PTF1A'
p6304
S'MECOM'
p6305
S'increases'
p6306
tp6307
(lp6308
s(S'arsenic trioxide'
p6309
S'HRAS MRNA'
p6310
S'increases'
p6311
tp6312
(lp6313
s(S'TCF3'
p6314
S'REPIN1'
p6315
S'increases'
p6316
tp6317
(lp6318
s(S'STAT6'
p6319
S'FOXO3'
p6320
S'increases'
p6321
tp6322
(lp6323
s(S'POU1F1'
p6324
S'POU2F1'
p6325
S'increases'
p6326
tp6327
(lp6328
s(S'RHOA/GTP'
p6329
S'ROCK'
p6330
S'increases_activity'
p6331
tp6332
(lp6333
s(S'PITPNA'
p6334
S'PI-4-5-P2'
p6335
S'translocates'
p6336
tp6337
(lp6338
s(S'MDM-2'
p6339
S'P14/19 ARF'
p6340
S'binds'
p6341
tp6342
(lp6343
s(S'TEAD1'
p6344
S'FOXO3'
p6345
S'increases'
p6346
tp6347
(lp6348
s(S'MYC'
p6349
S'MAX'
p6350
S'increases'
p6351
tp6352
(lp6353
g3779
aS'Together with its heterodimerization partner MAX, MYC controls the expression of many genes with broad physiological implications ('
p6354
aS'There are two pairs with the same TFs: CMYC and MAX.'
p6355
aS'The basic helix-loop-helix leucine-zipper transcription factor c-MYC (MYC afterward) heterodimerizes with MAX (MYC-associated factor X) ('
p6356
aS'To further corroborate a functional linkage of MYC with EGR1, we performed a STRING database analysis, including MYC, MAX, Ets1 and EGR1 (Figure '
p6357
aS'The carboxy-terminal basic helix-loop-helix leucine zipper (bHLH/LZ) domain of MYC is responsible for its hetrodimerization with MAX.'
p6358
aS'In addition to DNA binding, the MYC-MAX dimeric bHLH/LZ provides a docking platform for the interaction with other proteins, like the zinc finger transcription factor MIZ-1 ('
p6359
aS'MAX and E2F), which have been independently verified by validation experiments such as MYC promoter occupancy assays (Table '
p6360
aS'To aid in comparisons, we include MAX, which forms complexes with MYC, and USF1/2, which also recognizes the E-box sequence, in the MYC factor group.'
p6361
aS'We found a version of the E-box with additional specificity (MYC_disc1) that was highly enriched in USF1/2 bound regions (max 98-fold for USF2 versus <9-fold enrichment for MYC/MAX).'
p6362
aS'Morever, MYC_disc4 matches RFX5 and is enriched particularly for MAX-bound regions in H1-hESC and GM12878, and MYC_disc5 matches the CEBPB known motif and is enriched in MYC regions bound in unstimulated K562 cells.'
p6363
aS'MXI1, which was not included in the MYC factor group although it does interact with MAX to bind to MYC-MAX sites ('
p6364
aS'The transcription factors of the MYC/MAX/MAD network have evolved as critical regulators of many aspects of cell physiology, including proliferation, differentiation and apoptosis.'
p6365
as(S'GRB2:SOS1'
p6366
S'EGF:PHOSPHO-EGFR:PHOSPHO-SHC'
p6367
S'binds'
p6368
tp6369
(lp6370
s(S'NF1'
p6371
S'RUNX1'
p6372
S'increases'
p6373
tp6374
(lp6375
s(S'ZEB1'
p6376
S'GATA6'
p6377
S'increases'
p6378
tp6379
(lp6380
s(S'TBP'
p6381
S'EN1'
p6382
S'increases'
p6383
tp6384
(lp6385
s(S'FOXA1'
p6386
S'FOXD3'
p6387
S'increases'
p6388
tp6389
(lp6390
s(S'CART1'
p6391
S'EN1'
p6392
S'increases'
p6393
tp6394
(lp6395
s(S'MAX'
p6396
S'CEBPA'
p6397
S'increases'
p6398
tp6399
(lp6400
s(S'GATA6'
p6401
S'NRAS'
p6402
S'increases'
p6403
tp6404
(lp6405
s(S'PTF1A'
p6406
S'FOXO3'
p6407
S'increases'
p6408
tp6409
(lp6410
s(S'LEF1'
p6411
S'FOXA1'
p6412
S'increases'
p6413
tp6414
(lp6415
s(S'hsa-let-7g-5p'
p6416
S'KRAS'
p6417
S'decreases'
p6418
tp6419
(lp6420
s(S'ZBTB14'
p6421
S'CYP26A1'
p6422
S'increases'
p6423
tp6424
(lp6425
s(S'POU1F1'
p6426
S'FOXO4'
p6427
S'increases'
p6428
tp6429
(lp6430
s(S'PI3K'
p6431
S'PI-4-5-P2'
p6432
S'translocates'
p6433
tp6434
(lp6435
s(S'GABPB2'
p6436
S'NRAS'
p6437
S'increases'
p6438
tp6439
(lp6440
s(S'ELK1'
p6441
S'LEF1'
p6442
S'increases'
p6443
tp6444
(lp6445
s(S'Estrogens'
p6446
S'HRAS MRNA'
p6447
S'increases'
p6448
tp6449
(lp6450
s(S'CYP26A1'
p6451
S'CEBPA'
p6452
S'increases'
p6453
tp6454
(lp6455
s(S'SPI1'
p6456
S'POU2F1'
p6457
S'increases'
p6458
tp6459
(lp6460
s(S'PPARG'
p6461
S'CYP26A1'
p6462
S'increases'
p6463
tp6464
(lp6465
s(S'Asbestos, Serpentine'
p6466
S'HRAS PROTEIN'
p6467
S'increases'
p6468
tp6469
(lp6470
s(S'RET51/GFRALPHA1/GDNF/DOK1'
p6471
S'RASGAP'
p6472
S'binds'
p6473
tp6474
(lp6475
s(S'FOXO1'
p6476
S'GATA6'
p6477
S'increases'
p6478
tp6479
(lp6480
s(S'Cadmium'
p6481
S'KRAS PROTEIN'
p6482
S'increases'
p6483
tp6484
(lp6485
s(S'MAX'
p6486
S'EN1'
p6487
S'increases'
p6488
tp6489
(lp6490
s(S'TLX2'
p6491
S'NRAS'
p6492
S'increases'
p6493
tp6494
(lp6495
s(S'SREBF1'
p6496
S'CYP26A1'
p6497
S'increases'
p6498
tp6499
(lp6500
s(S'SMAD3'
p6501
S'MEIS1'
p6502
S'increases'
p6503
tp6504
(lp6505
s(S'Acetaminophen'
p6506
S'NRAS MRNA'
p6507
S'decreases'
p6508
tp6509
(lp6510
s(S'LEF1'
p6511
S'ETS1'
p6512
S'increases'
p6513
tp6514
(lp6515
s(S'SRF'
p6516
S'MEIS1'
p6517
S'increases'
p6518
tp6519
(lp6520
s(S'BRAF'
p6521
S'MKK3-MKK6'
p6522
S'increases_activity'
p6523
tp6524
(lp6525
s(S'HRAS/GTP'
p6526
S'RAF1'
p6527
S'adds_modification'
p6528
tp6529
(lp6530
s(S'MSX1'
p6531
S'CYP26A1'
p6532
S'increases'
p6533
tp6534
(lp6535
s(S'GATA4'
p6536
S'ETS1'
p6537
S'increases'
p6538
tp6539
(lp6540
s(S'E4F1'
p6541
S'FOXA1'
p6542
S'increases'
p6543
tp6544
(lp6545
s(S'FOXD1'
p6546
S'LEF1'
p6547
S'increases'
p6548
tp6549
(lp6550
s(S'CUX1'
p6551
S'MAX'
p6552
S'increases'
p6553
tp6554
(lp6555
s(S'CYP26A1'
p6556
S'CBFA2T3'
p6557
S'increases'
p6558
tp6559
(lp6560
s(S'CAM/CA2+'
p6561
S'KRAS ISOFORM 4B/GTP'
p6562
S'binds'
p6563
tp6564
(lp6565
s(S'MYOG'
p6566
S'STAT5A'
p6567
S'increases'
p6568
tp6569
(lp6570
s(S'MYOD1'
p6571
S'STAT5A'
p6572
S'increases'
p6573
tp6574
(lp6575
s(S'HNF1A'
p6576
S'POU3F2'
p6577
S'increases'
p6578
tp6579
(lp6580
s(S'EPH'
p6581
S'EPHR'
p6582
S'binds'
p6583
tp6584
(lp6585
s(S'PDGF:PHOSPHO-PDGF RECEPTOR DIMER'
p6586
S'GRB2:SOS1'
p6587
S'binds'
p6588
tp6589
(lp6590
s(S'HRAS/GTP'
p6591
S'PI3K'
p6592
S'increases_activity'
p6593
tp6594
(lp6595
s(S'RUNX1'
p6596
S'TLX2'
p6597
S'increases'
p6598
tp6599
(lp6600
s(S'MYOG'
p6601
S'CYP26A1'
p6602
S'increases'
p6603
tp6604
(lp6605
s(S'PAX2'
p6606
S'EN1'
p6607
S'increases'
p6608
tp6609
(lp6610
s(S'TFCP2'
p6611
S'CYP26A1'
p6612
S'increases'
p6613
tp6614
(lp6615
s(S'hsa-miR-145-5p'
p6616
S'NRAS'
p6617
S'decreases'
p6618
tp6619
(lp6620
s(S'KAT2B'
p6621
S'GATA1'
p6622
S'increases'
p6623
tp6624
(lp6625
s(S'P-EGFR MUTANTS:P-Y349,350-SHC1'
p6626
S'GRB2:SOS1'
p6627
S'binds'
p6628
tp6629
(lp6630
s(S'E2F1'
p6631
S'MECOM'
p6632
S'increases'
p6633
tp6634
(lp6635
s(S'GNB1/GNG2'
p6636
S'SRC'
p6637
S'adds_modification'
p6638
tp6639
(lp6640
s(S'ZBTB14'
p6641
S'MAX'
p6642
S'increases'
p6643
tp6644
(lp6645
s(S'RALGDS'
p6646
S'P21 RAS:GTP'
p6647
S'binds'
p6648
tp6649
(lp6650
s(S'RHOA/GTP'
p6651
S'ROCK2'
p6652
S'increases_activity'
p6653
tp6654
(lp6655
s(S'NR1H3'
p6656
S'FOXD3'
p6657
S'increases'
p6658
tp6659
(lp6660
s(S'TFAP4'
p6661
S'GATA1'
p6662
S'increases'
p6663
tp6664
(lp6665
s(S'FOXA1'
p6666
S'GATA6'
p6667
S'increases'
p6668
tp6669
(lp6670
s(S'GRB2:SOS1'
p6671
S'P-SHC'
p6672
S'binds'
p6673
tp6674
(lp6675
s(S'E2F1'
p6676
S'FOXO3'
p6677
S'increases'
p6678
tp6679
(lp6680
s.